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No two individuals are identical. This is true at the genetic level 
and at the phenotypic level. One of the traits that varies between 
populations is toxicant susceptibility: some individuals are sensitive to 
the effects of environmental chemical exposure, and others are 
resistant. This body of work aims to address the impact of genomic copy 
number variants (CNV)—large (>1 Kb) duplications or deletions across 
the genome—on the toxicant-susceptibility phenotype. 
Herein I have characterized copy number variants across three 
commonly used laboratory strains of zebrafish (Danio rerio) and 
identified mRNA expression phenotypes in the same strains. I found that 
males and females have only a 14% overlap in differentially expressed 
mRNA transcripts across three common laboratory strains, congruent 
with the growing body of work identifying sex- and strain-specific 
phenotypes in zebrafish. Furthermore, I identified two strain-specific 
response quantitative trait loci (QTL) that explain about a third of the 
variation in susceptibility to PCB and tested the response QTL using 
targeted CRISPR-Cas9 editing of the CNV involved. Overall, this body of 
work defines CNV and mRNA expression variation across zebrafish 
strains, identifies CNV causal in the PCB-susceptibility phenotype, and 
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Toxicology as a framework 
In toxicology, risk is defined as the product of toxicity and 
exposure, where exposure is comprised of both dose and duration. To 
determine risk we perform a formal risk assessment, which is a highly 
regulated process typically pertaining to human and/or environmental 
health. Currently there are 97 formal guidance documents from the 
United States Environmental Protection Agency (US EPA) that direct all 
aspects of human health risk assessment. To determine the human 
health risk of a compound, regulators follow four main steps of 
assessment: hazard identification, dose-response assessment, 




Figure 1.1: The 4 steps of risk assessment. Dose-response and exposure 




In human health risk assessment, hazard identification is initiated 
through a literature review process where existing data are assessed for 
evidence of potential health effects in humans, such as cancer or death. 
The two key components of hazard identification, toxicokinetics and 
toxicodynamics, include assessment of compound distribution (i.e., 
where it goes in the body), compound metabolism or elimination (i.e., 
how long it stays), and the effects that the chemical has on the body. 
The US EPA focuses its hazard identification for potential carcinogens on 
mode of action analysis, where the key chemical, molecular, cellular, 
and organismal events are delineated and the “weight of evidence” of 
adverse outcomes at any of the key events resulting in descriptors of 
the compounds ability to induce carcinogenic effects in humans.  
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If a compound is deemed potentially hazardous, it is then 
assessed for a dose-response relationship. Generally, as the dose 
increases the biological response also increases, but there is a lower 
limit at which adverse effects are not observed. This theory was 
originally postulated by Paracelsus in the 15th century, who stated, 
“solely the dose determines that a thing is not a poison”2, and manifests 
in modern toxicology as two dose-response criterial: NOAEL and LOAEL. 
The NOAEL is the no observable adverse effect level, where no adverse 
effects are observed at a known concentration and the LOAEL is the 
lowest observable adverse effect level. Similarly, the benchmark dose is 
another measurement that involves modeling NOAEL and LOAEL data to 
predict a single point-of-departure value where the dose induces a 
response3.  
Exposure assessment goes hand-in-hand with dose-response 
assessment. At this step the extent of exposure is assessed: who is 
exposed, at what interface is exposure occurring (skin, lungs, eyes, 
etc.), and what is the duration of the exposure? Oftentimes it is quite 
difficult to clearly delineate answers to these questions in humans, so 
epidemiologic analyses and extrapolations from body burden studies are 
used to estimate the dose experienced during exposure4. 
The final step in human health risk assessment is risk 
characterization. This step integrates the conclusions from hazard 
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identification and hazard assessment (dose-response plus exposure) 
into an overarching conclusion about the risk of the compound. The final 
risk characterization is used by regulators and policy makers to direct 
public health using data that support the extent and direction of human 
health outcomes following exposure5. Risk characterization ultimately 
shapes policy that directs the prioritization of legacy chemical clean-up 
(e.g., PCB) and the introduction of new chemicals in commercial 
application. 
One of the most crucial aspects of risk assessment is setting a 
reference dose for safe levels of exposure. Reference doses are 
calculated using a point-of-departure estimate, such as NOAEL, LOAEL, 
or benchmark dose, and applying uncertainty factors and modifying 
factors (Equation 1.1). 
 





Uncertainty factors are determined on a case-by-case basis, but 
consist of four main components with values ranging from 0.1-10: 
human variability, animal to human extrapolation, sub-chronic data 
(i.e., acute), and point-of-departure uncertainty. Additionally a 
modifying factor of up to a value of 10 can be assigned for the level of 
completeness in the dataset used in the hazard assessment. Let’s look 
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at an example using an acute exposure study in rats to determine a 
reference dose. In this study the authors determined a LOAEL of 0.1 
mg/kg/day for their endpoint. To calculate a reference dose we would 









The uncertainty factors for human variation (UFhuman) and animal 
to human extrapolation (UFinterspecies) can both be split into 
toxicodynamic and toxicokinetic subsets, but in this case we don’t have 
any information on either uncertainty factor, so their values will both be 
assigned the maximum value of 10. Because our rat study was not a 
chronic study we need to include a sub-chronic uncertainty factor of 10 
(UFsub-chronic) and because we used a LOAEL value and not a NOAEL value 
(i.e., there was no NOAEL identified in our rat study) we also need to 
include a point-of-departure uncertainty factor of 10 (UFpoint of departure). 
Finally, this is the only study that has been performed on our compound 
of interest, so the breadth of data is extremely lacking and we need to 
assign a modifying factor of 10 (MFdatabase). In this case our final 
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reference dose would be 1 ng/kg/day in humans (see worked example). 
So at 1 ng/kg/day we would not expect to see any adverse health 
outcomes in humans. This is an extremely conservative estimate and 





















One of the areas in which we can refine our uncertainties when 
determining reference dose is human variation. Toxicodynamic and 
toxicokinetic properties are both influenced by genetic variation. A study 
investigating the toxicity and efficacy of methotrexate for the treatment 
of psoriasis found genetic variants that caused changes in the number 
of receptors for and transporters of the drug, which directly affected the 
dynamics of the system6. Genetic polymorphisms in many isoforms of 
cytochrome P450, a family of metabolic enzymes responsible for 
xenobiotic metabolism, have been identified and linked to altered 
metabolism of many therapeutic compounds7 (e.g., kinetics).  
Understanding the normal variation that exists in humans and how it 
affects the dynamics and kinetics of exposure would be a huge 
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advancement that could be directly translated into reference dose 
calculations and the overall risk assessment procedure. 
 
Harnessing human variation 
In the last few decades huge strides have been made in human 
genetics. In 2001 the first draft of the human genome was released8 
and as of 2017 the human reference genome is now in its 38th release 
(GRCh38) and contains alternate loci representing significant variation 
in 178 regions9. Large scale efforts to identify global genetic variation 
began with the HapMap Project in 2003, which focused on identifying 
single nucleotide polymorphisms (SNPs) that were inherited as blocks10. 
The HapMap Project was built on the foundation that many SNPs were 
observed to exist in linkage disequilibrium and inherited as specific 
haplotypes. Identification and classification of haplotypes would 
decrease the number of SNPs required to identify variant regions specific 
to diverse populations and facilitate discovery of gene-disease 
associations. In 2005 the first haplotype map of the human genome was 
released and contained over 1 million SNPs11. In 2007 a second 
generation haplotype map containing 3.1 million SNPs was released12 
and in 2010 the International HapMap Consortium expanded their 
dataset from 270 individuals from 4 global populations to 1,184 
individuals from 11 global populations to sharpen the resolution on rare 
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variants and included the addition of genomic copy number variants 
(CNVs)13. 
As understanding of variation in the human genome grew and the 
limitations of small sample sizes (<300 individuals) to detect rare 
variants became apparent, a new large-scale genomic variation project 
began. In 2008 the 1000 Genomes Project aimed to sequence at least 
1000 individuals to investigate variants occurring in at least 1% of the 
population with coverage of genic variants found at 0.1% of the 
population14. In 2015 the 1000 Genomes Project had sequenced 2,504 
people across 5 continents and 26 populations and found that the typical 
genome differs from the human reference genome at 4.1-5.0 million 
sites and variants differ greatly among populations15.  With this new 
level of population variation, the 1000 Genomes Project established that 
individual genomes contain 2,100-2,500 structural variants that affect 
4-5 times as many nucleotides as SNPs and short insertion-deletions 
(indels). Individuals harbor 18.4 Mb of structural variants per diploid 
genome (8.9 Mb per haploid genome), largely comprised of multiallelic 
CNV and biallelic deletions16. 
CNV have shaped human diversity on the evolutionary scale by 
imparting selective advantages or disadvantages17 through alteration of 
gene expression by direct interaction (overlap with a gene) or indirect 
regulatory mechanisms18. Moreover, most structural variants that alter 
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gene expression do so through enhancers and other regulatory elements 
(88.3%), not through direct interaction with gene-coding regions19. In 
human health, CNV are associated with Mendelian diseases (e.g., 
Charcot-Marie Tooth neuropathy20 and Williams-Beuren syndrome21), 
complex diseases (e.g., diabetes22 and psoriasis23), and non-pathogenic 
phenotypes (e.g., salivary amylase production24). Additionally, CNV 
cause pharmacogenomic phenotypes25 where variable copy number 
across xenobiotic metabolism genes alter the rate of metabolism 
(pharmacokinetics) and if CNV interact with transporters or receptors 
they can alter biological activity (pharmacodynamics). 
In an effort to understand the effect of human variation on toxicity 
and refine the human variation uncertainty factor in reference dose 
determination, 179 chemicals were screened for cytotoxicity in  
lymphoblastoid cell lines from 1,086 individuals from 9 populations 
across 5 continents sequenced by the 1000 Genomes Project26. In this 
study about half of the tested compounds had a range of toxicity that 
would be captured by the 10½ uncertainty factor for interindividual 
toxicodynamic variability when calculating reference doses. A portion of 
the tested compounds had interindividual variation greater than a factor 
of 10, indicating that the uncertainty factors are woefully inadequate for 
some chemicals (Figure 1.2). Unfortunately, one of the weaknesses of 
lymphoblastoid cell lines is CNV artifacts due to differences in replication 
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timing relative to primary cell lines27. This makes extrapolation of copy 
number effects between systems extremely difficult. 
 
Figure 1.2: B) Histogram of the toxicodynamic variability factor 10(q50–
q01) for 149 compounds across 1,086 cell lines. The inset shows the 
relationship between range and median estimated EC10 for each 
chemical. C) Cumulative distribution functions for the in vitro 
toxicodynamic variability factor shrunken to account for technical 
variability across 149 compounds and the human in vivo toxicodynamic 
variability factors across 34 compounds28. D) Hierarchical clustering for 
the 179-length profiles of mean EC10, computed within each population, 
and shown by continental ancestral origin of the population. AM, 
Americas. Image and description adapted from work by Abdo et al., 
201526. 
 
Incorporating human variability is the next great challenge in 
toxicology. There is clear evidence that the current practice of generic 
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uncertainty factors in reference dose calculations are inadequate, but 
our knowledgebase of the driving factors behind interindividual 
variability is also inadequate. Toxicity clades out by distinct genetic 
populations (Figure 2c), indicating that toxicodynamic and toxicokinetic 
phenotypes may be shared by genetically similar groups. It is an 
extremely complex challenge to study this phenomenon in humans due 
to uncontrollable confounding factors such as socio-economic and health 
status. Other systems, including model organisms, may be the answer 
to delineating the myriad factors involved in interindividual variation and 
population-based variation, including the role that CNV play in toxicity. 
 
Evidence of resistance to toxic chemicals in wild populations 
Atlantic killifish (Fundulus heteroclitus) are estuarine fish found 
along the coast of the Eastern United States. These fish have adapted 
to local anthropogenic contamination in several locations such as 
Newark Bay (New Jersey)29, the Elizabeth River (Virginia)30,  New 
Bedford Harbor (Massachusetts)31, and the Hudson River (New York)32. 
In each location, high levels of aryl hydrocarbon mixtures (largely 
polychlorinated biphenyls, PCBs) are present in the sediments and are 
generally toxic to resident organisms. At these locations, however, 
Atlantic killifish have adapted to be resistant to high levels of pollution. 
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Different mechanisms have been tied to the resistant phenotype 
in Atlantic killifish. Generally, tolerance is associated with a blockade of 
the aryl hydrocarbon receptor (AHR) signaling pathway33. Aryl 
hydrocarbons, such as PCBs, impart toxicity through a highly conserved 
AHR signaling cascade34 (Figure 1.3). Prior to ligand binding, AHR exists 
in the cytosol bound to several chaperone proteins such as heat shock 
protein 90 (HSP90), p23, and AHR-interacting protein (AIP). After 
binding to a ligand, the AHR complex translocates to the nucleus where 
it dissociates with the chaperone proteins and binds to AHR nuclear 
translocator protein (ARNT). The AHR-ARNT complex then binds directly 
with DNA at xenobiotic response elements (XREs) and induces 
transcription of a suite of genes, including cytochrome P450 1A (CYP1A) 
(reviewed in35). CYP1A and other cytochrome P450 proteins are 
responsible for xenobiotic metabolism and both the parent compound 
(AHR ligand) and its metabolites can exert toxic effects. 
13 
 
Figure 1.3: The AHR signaling cascade. After binding with a ligand, AHR 
translocates to the nucleus, directly binds to the DNA at xenobiotic 
response elements, and induces translation of a suite of genes, including 
CYP1A. Adapted from Hall, 201434. 
 
The genetic component of the toxicant susceptibility phenotype in 
killifish was tested by a common-garden experiment in which tolerant 
populations were reared in a clean environment for two generations to 
isolate the heritable component of tolerance, and then challenged with 
known concentrations of a specific PCB congener (PCB-126)36. The study 
found that tolerance was heritable for up to two generations indicating 
that the phenotype is genetically based. Further work identified adaptive 
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selection of SNPs across AHR genes—which are known mediators of 
PCB-126 toxicity in killifish37—in the New Bedford Harbor population38. 
The Atlantic Tomcod (Microgadus tomcod) is another example of 
local adaptation to highly contaminated sites. Exposure to two aryl 
hydrocarbons, benzo[a]pyrene and PCB-77, does not induce CYP1A 
mRNA expression in fish from the contaminated site, but fish from a 
nearby clean site have robust transcriptional responses to the same 
exposure32 (Figure 1.4). The mechanism behind this resistance has been 
identified as a 6 basepair deletion in the AHR2 gene that results in a two 
amino acid deletion in the mature protein and is highly penetrant in 
populations at polluted sites39. 
 
Figure 1.4: CYP1A mRNA expression levels (mean and 95% CIs, 
expressed in OD units) in juvenile tomcod from a contaminated (Hudson 
River) and clean (Miramichi River) site injected intraperitoneally with 10 
ppm Benzo[a]pyrene, corn oil vehicle, or 10 ppm PCB-77. Numbers 
above bars represent sample size. Image and description adapted from 
Yuan et al., 200632. 
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Repeated observations of toxicity-resistance phenotypes in 
multiple species are strong evidence of the adaptive advantage that 
these populations have in polluted environments. The genome of the 
Atlantic killifish was assembled in 2015 and a linkage map was published 
shortly thereafter, facilitating a deeper understanding of the genetic 
mechanisms behind the resistance phenotype. The genetic linkage map 
identified 24 linkage groups (putative chromosomes) and supports a 
high degree of synteny between killifish and medaka, with slightly less 
synteny between killifish and zebrafish40. Although zebrafish are less 
syntenic with killifish than medaka, they still share several quantitative 
trait loci (QTL) identified as the genetic basis for aryl hydrocarbon 
resistance in killifish41. 
 
Zebrafish as a model system to study the effects of genetic variation on 
toxicity 
The Atlantic killifish and Atlantic tomcod are excellent examples of 
repeated evolution of a toxicant-resistance phenotype through 
convergent genetic mechanisms. However, the complete picture of the 
genetics driving this phenotype is unclear due to unexplained variance 
and a lack of genomic tools to discover the cause of the variance. Herein 
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lies the strength of the well-developed model organism, the zebrafish 
(Danio rerio). 
Zebrafish were first used as a model system in the 1940s and 
following the establishment of several laboratory strains in the 1990s, 
their popularity has exploded (Figure 1.5). Since the mid-2000s over 
1000 studies using zebrafish are published every year (searchable in 
NCBI PubMed using “zebrafish” or “Danio rerio” keywords) and that 
number has only continued to grow. In 2017 the number of zebrafish 
publications hit its current peak of 2940. 
 
 
Figure 1.5: Publication count per year, as indexed by NCBI's PubMed 
using "zebrafish" or "Danio rerio" as keywords. 
 
The rise of zebrafish as a model system is due to several factors. 
The zebrafish shares basic body design with other vertebrates. Zebrafish 
reach sexual maturity by 3 months, which facilitates genetic crosses and 
multi-generational studies. Housing and husbandry are relatively cheap 
and easy. External fertilization, large clutches of eggs (averaging ~200 
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embryos per spawning event), clear bodies until juvenile stage, and 
rapid development (primary organogenesis begins at 10 hours and is 
complete by 48 hours42) make studying early development easier than 
mammalian systems. The zebrafish also boasts a completely sequenced 
genome with 71% of zebrafish genes having at least one homolog in the 
human genome43. With a sequenced genome comes a complete set of 
genetic tools such as morpholinos, CRISPR-Cas9, and transgenic 
strains.  
Additionally, zebrafish have a toxicant-resistance phenotype, 
similar to the phenotype observed in Atlantic killifish and Atlantic 
tomcod. Zebrafish larvae exposed to PCB-126 have ranges of 
developmental toxicity between 9 and 336 ppb across genetically 
distinct laboratory strains44 (Figure 1.6). This range of interstrain 
variation exceeds a factor of 10, such as is used in reference dose 
assessment, and can serve as a malleable laboratory model of toxicity 
variation across populations. Although AHR2 was identified as one of the 
genetic drivers of the resistance phenotype, only 24% of the phenotypic 
variance could be explained by QTL, leaving a large gap in our 





Figure 1.6: Median effective concentration (EC50) of early-life stage 
toxicity (abnormal looping of the heart, pericardial and yolk-sac edema, 
reduced heart rate, impaired swim bladder inflation, and craniofacial 
malformations). Branch lengths reflect genetic distance; numbers in 
parentheses represent 95% confidence intervals. Image and description 
adapted from Waits and Nebert, 201144. 
 
There is a fair amount of information on the genetic variation 
between common laboratory strains in zebrafish. Most of the focus has 
been on SNP variants between strains. In fact, zebrafish strains clade 
out with high support using SNP markers with over 37.9 million SNPs 
currently described across the 1.5 Gb zebrafish genome45. Beyond SNPs, 
there is also a detailed analysis of intrastrain CNV across three common 
laboratory strains and one wild strain of zebrafish. Across strains, there 
are approximately 1900-3400 CNV, of which only about 500 are shared 
across all strains, indicating that strains have their own unique set of 
CNV46, similar to the case with distinct human populations16. These 
factors prime the zebrafish to be a uniquely helpful tool for basic 
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research into the genetic mechanisms driving complex phenotypes like 
toxicant susceptibility. 
To test the likelihood that CNV play a role in toxicant susceptibility, 
I performed a basic assessment of direct and near-neighbor overlap of 
CNV in zebrafish with a thorough list of 70 genes that are differentially 
expressed in the toxicant-resistant Atlantic killifish phenotype relative 
to toxicant-sensitive populations47. Using NCBI’s blastn alignment tool48 
to assign zebrafish gene homologs (closest sequence match to the nr/nt 
database with an e-value > 1 x 10-10), I found 9 genes (12.9%) with 
directly overlapping CNV and 34 genes (48.6%) with a CNV within 100 
Kb up- or downstream in zebrafish (Supplemental data 1.1). These 
direct and near-neighbor hits indicate that CNV are likely interacting 
with transcriptional responses that drive the toxicant-susceptibility 
phenotype. 
 
A brief history of PCBs 
Polychlorinated biphenyls are a large class of aryl hydrocarbons 
comprised of 209 congeners with varying levels of chlorination of a 
biphenyl molecule (two connected benzene rings, Figure 1.7). PCBs are 
characteristically hydrophobic and lipophilic, have low vapor pressures, 
and are resistant to chemical reactions (including degradation)49. As the 
number of chlorine molecules increases, the stability of the compound 
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increases. These properties make PCBs excellent coolants, flame 
retardants, and plasticizers, but also result in long half-lives and 
bioaccumulation in the food web. 
 
 
Figure 1.7: Chemical structure of PCB. Image from Crinnion, 201150. 
 
There are two general classes of PCB congeners determined by 
the position and number of chlorines: nonplanar (mono-ortho-
substituted) and coplanar (non-ortho-substituted). Coplanar congeners 
exert toxic dioxin-like effects by binding and activating the AHR 
signaling cascade51,52. In 1979 the US EPA banned the production and 
use of PCBs following evidence that bioaccumulation in birds caused 
brittle shells through aberrant calcium metabolism, a large-scale 
poisoning incident in Yusho, Japan where over 1000 people consumed 
food cooked in contaminated cooking oil, and a forced cull of thousands 
of chickens and eggs that were fed contaminated feed (as reviewed 
in53). 
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The World Health Organization developed a comparative scale to 
assess the toxicity of dioxin and dioxin-like compounds called a Toxic 
Equivalency Factor (TEF). Dioxin (2,3,7,8-TCDD) is set at the maximum 
TEF of 1 and related compounds are assigned a TEF relative to dioxin 
after review of published toxicity data54. The most toxic PCB listed in the 
TEF documentation is PCB-126 (3,3’,4,4’,5-pentachlorobiphenyl) with a 
TEF of 0.1. Other coplanar (non-ortho-substituted) PCBs have TEF 
values between 0.03-0.0001, while nonplanar (mono-ortho-substituted) 
PCBs have TEF values of 0.00003. PCB-126 is heavily chlorinated (with 
5 chlorines) and has a half-life on the order of 20-30 years in adults55. 
The total body burden of PCBs in humans has steadily declined 
since the ban in 1979, but a national census of human exposure to 
environmental chemicals by the US Centers for Disease Control and 
Prevention (CDC) found 34 of 38 PCB congeners in virtually all people 
tested56. The current body burden of PCB-126 in the average American 
is 100 ppq in the serum (16.3 pg PCB-126/g lipid). In utero exposure to 
PCBs can result in immune deficiency and neurological deficits and 
dietary exposure (the most common route of exposure) can cause 
reproductive problems in men and women, hypothyroidism, and 
increases in the risk of type II diabetes, lung cancer, and liver cancer 
(as reviewed in50).  
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Because of its highly toxic effects, long-half life, and 
bioaccumulative properties, PCB-126 serves as a good proxy for the 
effects of total PCB burdens (from mixtures of multiple PCB congeners 
with assumed additive effects) in controlled studies. There is extensive 
documentation of the developmental effects of PCB-126 exposure across 
multiple fish species, including zebrafish. In zebrafish, developmental 
toxicity is largely characterized by pericardial and yolksac edema, delay 
of swim bladder inflation, elongated and/or unlooped heart (abnormal 
cardiac development), reduced heart rate, and malformation of the 
spine57–59. These physical manifestations of PCB-126 toxicity are easily 
observable in controlled laboratory studies. The combination of a clear 
developmental toxicity paradigm for PCB-126 and well-characterized 
genomic variation make the zebrafish the ideal system to assess the 
influence of genetic variation on susceptibility to toxicants. 
 
Rationale for chapters 
Our current knowledge of CNV in zebrafish was built on within-
strain (intrastrain) comparisons. While this allows some comparison of 
shared CNV across strains, it does not fully capture the interstrain 
variability in zebrafish. To improve upon this I have assessed three 
common laboratory strains of zebrafish using a reciprocal comparison 
study design to maximize identification of interstrain variation. I present 
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this work in Chapter 2 “An Interrogation of Shared and Unique Copy 
Number Variants across Genetically Distinct Strains of Zebrafish”. 
Herein I present a set of 1351 CNV that vary across strains and test a 
set of ten identified CNV using multiple molecular methods (quantitative 
PCR (qPCR) and long amplification standard PCR). I also present that 
CNV that directly overlap a gene or fall within 5 Kb up- or downstream 
of a gene are likely to cause variation across introns, coding sequence, 
or untranslated regions at the start or end of genes.  
Because we know that there is wide genetic variation across 
zebrafish strains and I have predicted transcriptional effects of CNV that 
vary across strains, we can hypothesize that there is also standing 
variation in gene expression across strains. In Chapter 3 “Baseline 
mRNA expression differs widely between common laboratory strains of 
zebrafish” I characterize the normal transcriptional profiles in the same 
set of commonly used zebrafish strains using microarrays. Surprisingly, 
I found large differences between males and females, as well as large 
differences between strains. A total of 421 unique mRNA transcripts 
were significantly differentially expressed across strains. This study sets 
the stage for further exploration of phenotypes affected by genetic and 
transcriptional variation. 
In Chapter 4 “Response eQTL analysis of low-dose PCB exposure 
connects genomic copy number variants to susceptibility” I explore the 
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relationship between genomic CNV and the PCB-susceptibility 
phenotype. Using matched CNV genotypes and PCB-induced gene 
expression phenotypes, I performed an extensive expression QTL 
analysis to identify CNV drivers of the phenotype. After mapping 
phenotypes of exposed and unexposed zebrafish to CNV, I found two 
response QTL (eQTL responsive to PCB exposure) that are strain-
specific. 
To test the reQTL that I identified as drivers of the PCB-
susceptibility phenotype, I performed a functional study using CRISPR-
Cas9 to selectively edit the CNV in the two reQTL. In Chapter 5 
“Targeted CRISPR-Cas9 Editing of Genomic Copy Number Modulates 
PCB-Susceptibility Phenotype” I successfully target and edit the CNV 
regions of both reQTL and show a reversion in phenotype where a PCB-
resistant strain becomes extremely sensitive and a PCB-sensitive strain 
becomes slightly more resistant. This serves as proof-of-principle that 






An Interrogation of Shared and Unique Copy Number Variants 
across Genetically Distinct Zebrafish Strains 
 
Abstract 
Zebrafish (Danio rerio) are a widely utilized model system for 
human disorders, but common laboratory strains have distinct 
behavioral and physiological differences. Accompanying these known 
strain differences, commonly used “wildtype” zebrafish strains have 
both shared and unique suites of single nucleotide polymorphisms and 
copy number variants (CNV). Despite this, genomic variation is often 
ignored in study design and the strain used is often not mentioned. The 
goal of this study is to assess CNV across three common laboratory 
strains of zebrafish—AB, Tubingen (TU), and WIK—and provide this 
dataset as a tool for the zebrafish community. Herein we identify 1351 
CNV regions within the most recent genome assembly (GRCz11) 
covering 1.9% of the zebrafish genome (31.7 Mb). CNV were found 
across all chromosomes and 2200 genes (5121 transcripts) lie within ± 
5 Kb of identified CNV, pointing to likely cis regulatory actions of CNV 
on nearby gene neighbors. We have created a Public Session accessible 
on the UCSC Genome Browser to view CNV from this study titled 
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Zebrafish are an important genetic model, but the 
acknowledgement and incorporation of genomic variation across 
common lab strains into study design has been slow. It is well 
established that zebrafish strains contain many shared and unique 
single nucleotide polymorphisms (SNPs)45,60–62 and copy number 
variants (CNVs)46,63 with several groups diligently working to describe 
and characterize differences between strains at the genotypic and 
phenotypic levels. The phenotypic effects of these genetic differences 
are not well understood and likely manifest as observable, but as-of-yet 
unidentified, variation between strains. To this end, several studies have 
described behavioral and physiological differences between strains such 
as differences in sex-determination64, fear-related behavior65, social 
preference66, stress67, susceptibility to toxicants44, locomotion68, and 
growth performance69. 
CNV, which cover 5-10% of the human genome70, can directly and 
indirectly affect gene expression via gene dosing71 and principally act 
through enhancers and other regulatory elements19. CNV can be 
positively or negatively correlated with gene expression72 and result in 
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wide-ranging phenotypic effects like testosterone metabolism73, the 
ability to digest starch24, or complex diseases such as autism and 
schizophrenia (reviewed in74,75). As zebrafish continue to grow as an 
important model system for basic research, it is imperative to expand 
our knowledge of the genomic variation within the species. Previous CNV 
identification in zebrafish focused on within-strain (intrastrain) 
variation. This study aims to describe zebrafish genomic copy number 
variation across commonly used laboratory strains (interstrain 
variation). By providing these data to the global zebrafish community, 
we hope to highlight the important role that copy number variation has 
on phenotypes across strains in support of incorporating this information 
into study design and publication. This is of critical importance to the 
zebrafish community because clearly defining genomic variation will 
result in better replication and translation of our research into other 
model systems, for human health applications, and for application to 
ecological systems.  
 
Materials and Methods 
Animal care and husbandry 
All zebrafish husbandry and experimental procedures were 
performed following protocols approved by Portland State University’s 
Institution Animal Care and Use Committee in accordance with the 
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National Institutes of Health Guidelines for Care and Use of Laboratory 
Animals and the Public Health Service Policy on Humane Care and Use 
of Laboratory Animals. Zebrafish were housed on an Aquaneering semi-
recirculating housing system at a density of 5 individuals per liter with 
10% daily water changes. Water temperature was maintained at 27.5°C 
and fish were kept on a 16 hour light, 8 hour dark photoperiod. pH and 
conductivity were maintained at approximately 7.4 and 1100 uS, 
respectively. Zebrafish were fed commercial flake food twice daily and 
supplemented with live Artemia and rotifers. This study used 3 strains 
of zebrafish: AB, Tuebingen (TU), and WIK. 
 
aCGH data analysis 
Microarray data were obtained from the National Center for 
Biotechnology Information (NCBI) BioProject portal (GEO Sample IDs: 
GSM839719, GSM839720, GSM839721)46. Array data are comprised of 
pooled DNA from 10 individuals each of AB, TU, and WIK strains run in 
a reciprocal design (AB vs TU, WIK vs TU, AB vs WIK) on custom-
designed Aligent Technologies SurePrint GS CGH microarrays. Arrays 
were designed against the zebrafish Zv8/danRer6 reference genome 
and had an average probe spacing of 1.4 kb. Copy number variants 
(CNV) were called using normalized signal intensity files within Nexus 
Copy Number software (version 5.1; BioDiscovery) and reported as log2 
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ratios. Log2 ratios with a three-probe running average greater than 2 
were identified as CNVs46. Microarray probe chromosomal locations were 
updated to the most recent zebrafish reference genome using the 
LiftOver tool in UCSC Genome Browser76 (Zv8  Zv9  GRCz10  
GRCz11). 
 
qPCR and standard PCR 
Quantitative PCR (qPCR) was performed across 10 regions 
identified as having a CNV using primers designed on Primer3Plus 
software77. DNA was isolated via standard phenol:chloroform extraction 
for 10 individuals from each strain and assayed across the 10 regions in 
triplicate on a 364-well plate format using Power SYBR Green Master 
Mix (Applied Biosystems). Fluorescence was measured on an Applied 
Biosystems 7900HT Real-Time PCR System.  The qPCR cycling protocol 
included preliminary dissociation (10 minutes at 95°C) and 35 cycles of 
annealing and extension (95°C for 15 seconds, 60°C for 30 seconds), 
per manufacturer’s protocol. A dissociation melt curve was also obtained 
to confirm single PCR products. Quantification of PCR product was 
performed using the ∆∆Ct method78 with an ultra-conserved element 
(UCE) as a standardized DNA copy number reference sequence46 and 
pooled DNA from AB, TU, or WIK strains as reference for each strain. 
Specifically, ∆CT = target - UCE and ∆∆CT = ∆CTindividual - ∆CTpool. 
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Pairwise comparisons were made between each strain and fold change 
was calculated as the inverse log2 of ∆∆CT (or 2-∆∆CT). 
Standard PCR was performed across 3 CNV regions confirmed by 
qPCR as an additional confirmation technique and further resolution of 
the region using Hot Start Taq 2X Master Mix (New England BioLabs) 
following the manufacturer’s protocol. DNA from 3 individuals per strain 
was extracted using a DNeasy Blood and Tissue kit (Qiagen). PCR 
products from 3 or 4 regions across each CNV were run on 1% agarose 
gels with Gel Red nuclear binding stain in 0.5X TBE at 110 volts for 45 
minutes and visualized on a digital gel imager. Bands were scored as 
present/absent and approximate size was noted. All qPCR and standard 
PCR primers, amplicon sizes, and locations are listed in Supplementary 
Table 2.1. 
 
Predicting effects of CNV 
Consequences of identified CNV were predicted using the Ensembl 
Variant Effect Predictor79. Briefly, effects of CNV were predicted for all 
RefSeq genes and transcripts falling within a very conservative zone of 
5 kb up- or downstream of the CNV location. CNV calls from the GRCz10 
assembly were used for this analysis as this is the most recent genome 




Across the reciprocal comparisons of pooled DNA from three 
zebrafish strains, we identified 1941 CNV regions in the Zv8 genome 
(Supplementary Table 2.2). Stepwise LiftOver to GRCz11 resulted in the 
loss of CNV calls due to a split across the region or partial deletion in 
newer versions of the reference genome. The largest loss in CNV calls 
resulted from the Zv8 to Zv9 LiftOver because of a major genome 
update. Zv9 to GRCz10 and GRCv10 to GRCz11 LiftOvers also resulted 
in the loss of some, but fewer, CNV calls. The final count of GRCz11 CNV 
calls was 1351 (Table 2.1) and the identified CNV regions non-
redundantly cover 1.9% of the zebrafish genome (31.7 Mb).  
 
Table 2.1: Summary of copy number count and type across four versions 
of the zebrafish reference genome. 
 
  Zv8 Zv9 GRCz10 GRCz11 
High Copy Gain 432 375 355 350 
Copy Number Gain 1036 731 631 626 
Copy Number Loss 154 128 116 112 
Homozygous Copy Loss 319 291 265 263 
Partially deleted in new -- 5 4 3 
Split in new -- 411 154 13 
 
We chose 10 random CNV regions to confirm by qPCR and further 
interrogate the putative effects of those CNV on the organism (Figures 
2.1 and 2.2). Of the 10 regions, 8 were fully confirmed by qPCR. Three 
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regions showed a loss in WIK (CNV_0311, CNV_0437, CNV_0968), two 
regions showed a gain in TU (CNV_0222, CNV_0900), two regions 
showed a loss in AB (CNV_0559, CNV_1736), and one region showed a 
loss in TU (CNV_0663). The data for one region (CNV_0302) were in 
disagreement; the array data and CNV call identified a loss in AB while 
the qPCR data showed a gain in TU. CNV_0572 was predicted to be a 
loss in WIK from array data, but qPCR failed to show any differences 
between strains. We further interrogated 3 of these regions by PCR to 
obtain a high resolution understanding of the loci (Figure 2.3) and were 
able to confirm the CNV across sub-regions approximately 3.7 Kb in size 
for CNV_0222, CNV_0311, and CNV_0900. Not all CNV are fully 
penetrant, as can be seen in CNV_0900.4 which as a gain in WIK across 





Figure 2.1: log2 ratios of microarray probes across chromosomal 
locations identified as CNV with corresponding qPCR log2 fold-change 
values. CNV_0222 = gain in TU, CNV_0302 = disagreement between 
CNV (loss in AB) and qPCR (gain in TU), CNV_0311 = loss in WIK, 
CNV_0437 = loss in WIK, CNV_0559 = loss in AB. Grey regions on log2 
ratio plots indicate location of CNV. Error bars represent standard 
deviation and large error bars indicate variation within the strain (i.e., 





Figure 2.2: log2 ratios of microarray probes across chromosomal 
locations identified as CNV with corresponding qPCR log2 fold-change 
values. CNV_0572 = not validated, CNV_0663 = loss in TU, CNV_0900 
= gain in TU, CNV_0968 = loss in WIK, CNV_1736 = loss in AB. Grey 
regions on log2 ratio plots indicate location of CNV. Error bars represent 
standard deviation and large error bars indicate variation within the 
strain (i.e., the loss or gain is not fully penetrant). 
 
 
Figure 2.3: Standard PCR across subsets of three CNV regions. Each PCR 
amplicon was approximately 3.7 kb in length. CNV_0222 is only present 
in TU, while CNV_0311 and CNV_0900 show some variation across 
strains, but the array-based CNV call is confirmed by qPCR and PCR data 
across multiple individuals. 
 
CNV were identified across all chromosomes, with the highest 
number of calls falling on chromosomes 3, 4, and 7 (Figure 2.4). We 
have created a Public Session accessible on the UCSC Genome Browser 
for the zebrafish community to view CNV data from this study titled 
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“danRer11 zebrafish CNV across strains” (as an example, see Figure 
2.5). Using the Ensembl Variant Effect Predictor we queried 1355 CNV 
(GRCz10) against the RefSeq database and found 2200 genes and 5121 
transcripts within ± 5 Kb of identified CNV. Of these genes and 
transcripts located proximal to CNV regions, 25% resulted in intron 
variants, 16% resulted in coding sequence variants, and 21% impacted 
3’ or 5’ UTRs (Figure 2.6 and Supplementary Table 2.3). 
 
 
Figure 2.4: Copy number counts across all chromosomes in GRCz11 by 
type (Homozygous copy loss, copy number loss, copy number gain, or 
high copy gain. 
 
 
Figure 2.5: UCSC Genome Browser view of chromosome 4 (GRCz11) 
with CNV locations in teal, RefSeq Genes in blue, and GenBank mRNAs 
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Figure 2.6: Predicted consequences of CNV that occur within 5 kb ± of 




In an effort to understand the effects of CNV on common lab 
strains, we searched for available datasets reflecting structural variation 
in zebrafish. The current NCBI structural variation database (dbVar, 
www.ncbi.nlm.nih.gov/dbvar) contains only human and great ape 
datasets and wholly excludes zebrafish data. The majority of available 
datasets incorporating CNV and phenotype are from humans, where 
much work has been done to associate structural variants to disease 
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phenotypes. The EMBL-EBI Database of Genomic Variants archive 
(DGVa, www.ebi.ac.uk/dgva) contains 200 genomic structural variant 
studies, but only a single study utilizes zebrafish (study ID: nstd62). 
The design of the single zebrafish study in DGVa used within population 
comparisons to identify strain-specific structural variation, and then 
used a subtractive model to infer between strain differences46. Therefore 
the majority of the structural variation presented in that study is within-
strain (intrastrain) variation. We also found one previous study that 
looked at copy number variation in the wild zebrafish strain ASWT80, but 
the strain is not widely used so the data are not directly applicable to 
most zebrafish investigators. Interestingly, we found no overlap in their 
copy number deletion or insertion loci with our dataset, which indicates 
that CNV are highly strain-specific. 
This study performed reciprocal comparisons between three 
common laboratory strains (AB, TU, and WIK) and found 1351 CNV 
regions covering 1.9% (31.7 Mb) of the current zebrafish genome 
assembly (GRCz11). The effects of these CNV on phenotype are not fully 
known, but 2200 genes comprised of 5121 transcripts fall within ± 5 kb 
of identified CNV. From studies in humans, we know that CNV can alter 
gene expression, often by acting through regulatory elements from up 
to 1 Mb away72, so the impact of these CNV is probably much larger 
than the 2200 genes that fall within 5 Kb. With over 5000 transcript 
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variants within 5 Kb up- or downstream of CNV, we predict that the 
expression of many of these transcripts likely vary across strains, 
dependent on copy number status. Previous work that characterized the 
CNV within strains found CNV cover approximately 15% of the zebrafish 
genome, but the experimental design focused on within-strain 
variation46. This analysis used pooled sample arrays (n=10 individuals 
per strain) and likely reduces the level of interstrain variation detected 
as only the most common variants are likely to be identified. We found 
1.9% of the zebrafish genome to be affected by high-confidence CNV 
that are unique across strains and have made these CNV loci available 
to the zebrafish community for further exploration.  
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Baseline mRNA expression differs widely between common 
laboratory strains of zebrafish 
Published in Scientific Reports, 8, 1–10 (2018). 
 
Abstract  
Common strains of wildtype zebrafish (Danio rerio) have unique 
genomic features including SNPs and CNV, but strain information often 
goes unreported in the literature. As a result, the confounding effects of 
interstrain variation makes repetition of studies in zebrafish challenging. 
Here we analyze hepatic mRNA expression patterns between three 
common zebrafish strains (AB, Tuebingen (TU), and WIK) using Agilent 
4x44K gene expression microarrays to establish baseline mRNA 
expression across strains and between sexes. We observed wide 
variation in sex-specific gene expression within AB and WIK strains (141 
genes in AB and 67 genes in WIK), but no significant variation between 
sexes within TU. After partitioning the dataset into male and female 
subsets, we detected 421 unique mRNA transcripts with statistically 
significant differential expression; 269 mRNA transcripts varied between 
males, 212 mRNA transcripts varied between females, and 59 mRNA 
transcripts varied across the three strains, regardless of sex. It is not 
surprising that mRNA expression profiles differ between sexes and 
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strains, but it is imperative to characterize the differences. These results 
highlight the complexity of variation within zebrafish and underscore the 
value of this model system as a valid representation of normal variation 
present in other species, including humans. 
 
Introduction 
Laboratory strains of zebrafish (Danio rerio) have discrete 
genomic backgrounds; they clade out with very high bootstrap support 
by distinct SNPs61 and have unique sets of copy number variant genomic 
regions46. Because of these genomic traits, zebrafish strains may be able 
to serve as a proxy to incorporate genetic variation into study design, 
similar to our understanding of the genomic variation in distinct human 
populations81. The human 1000 Genomes Project found that many 
common genetic variants are shared across populations, but rarer 
variants are generally only shared by closely related populations15. 
Analogous to distinct human populations, zebrafish strains have unique 
origin stories and genetic isolation between strains is maintained by 
strict husbandry practices.  
Commonly used zebrafish strains such as AB (ZFIN ID: ZDB-
GENO-960809-7), Tuebingen (TU; ZFIN ID: ZDB-GENO-990623-3), and 
WIK (ZFIN ID: ZDB-GENO-010531-2) have well-documented histories 
(Figure 3.1) and are easily obtainable for laboratory manipulations. The 
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AB line began from unknown zebrafish source stocks bought from two 
pet shops (pet shop A and pet shop B) in Albany, Oregon in the early 
1970s82. Haploid progeny from AB females were crossed with random 
AB males for approximately 70 generations until the early 1990s when 
six diploid progeny stocks (each from a distinct haploid female) were 
thoroughly intercrossed to produce the modern AB line (sometimes 
referred to as AB*). The current AB source stock is maintained through 
large group spawning crosses. The TU strain originated from a 
composite population of fish purchased from pet shops in 1994 and was 
maintained as an inbred strain in a lab in Tuebingen, Germany83,84. The 
WIK strain (“Wild India Kolkata”) originated from a single pair mating of 
wild caught fish in 199785. The establishment and maintenance of these 




Figure 3.1: History of strain establishment for common laboratory 
strains of zebrafish. AB, TU, and WIK are three popular zebrafish strains 
used in genetic, developmental, and toxicological research with very 
different origin stories. 
 
The high homology between humans and zebrafish—71% of 
human genes have at least one zebrafish ortholog and 69% of zebrafish 
genes have at least one human orthologs43—makes zebrafish an 
excellent model to study development, genetics, and toxicology. 
Unfortunately only 83% of transgenic and 46% of non-transgenic wild 
type strains of animal models are actually identified in the published 
literature86 indicating that strain-based genetic variation is largely 
overlooked or ignored. Behavioral traits associated with domestication 
in wild versus lab-reared zebrafish are associated with differential mRNA 
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expression in the brain65, indicating that the genetic isolation and 
population bottleneck inherent during laboratory strain establishments 
of zebrafish can create distinct characteristics between strains. Sex is 
an additional factor that drives differential mRNA expression between 
strains, mostly associated with hormone biosynthesis87. The goal of this 
study is to identify baseline liver mRNA expression variation between 
different zebrafish strains and between sexes in support of the growing 
recognition of normal variation between strains and populations88,89 in 
an organismal and physiological context to support zebrafish as a strong 
model for translational research. 
 
Methods 
Animal care and husbandry 
All zebrafish husbandry and experimental procedures were 
performed following protocols approved by Portland State University’s 
Institution Animal Care and Use Committee in accordance with the 
National Institutes of Health Guidelines for Care and Use of Laboratory 
Animals and the Public Health Service Policy on Humane Care and Use 
of Laboratory Animals. Zebrafish are housed on an Aquaneering semi-
recirculating housing system at a density of 5 individuals per liter with 
10% daily water changes. Water temperature is maintained at 27.5°C 
and fish are kept on a 16 hour light, 8 hour dark photoperiod. pH and 
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conductivity are maintained at approximately 7.4 and 1100 µS, 
respectively. Zebrafish are fed commercial flake food twice daily and 
supplemented with artemia and rotifer live food. AB, TU, and WIK strains 
are maintained in-house by random single pair breeding. Larvae are 
screened for developmental abnormalities and 10 individuals from 25 
pairs are randomly selected for the succeeding generation. The fish used 
in this study were second generation adults originally sourced from ZIRC 
(Eugene, OR) as batches of 100 embryos. All tissues were collected from 
healthy adults between 12 and 14 months old. At the time of dissection 
males weighed 331.7 ± 100.4 mg (mean ± SD) and females weighed 
346.6 ± 90.7 mg. Male liver weights ranged from 0.002-0.021% of 
whole body weight and female liver weights ranged from 0.003-0.028% 
of whole body weight. 
 
Nucleic acid isolation 
White muscle and liver tissues were dissected from 3 males and 3 
females from AB, TU, and WIK strains (n=6/strain; n=18 total) and 
disrupted with a mortar and pestle prior to homogenization by passing 
the samples through a nuclease-free syringe and needle in beta-
mercaptoethanol lysis buffer. DNA was extracted on Qiagen DNeasy 
columns (Qiagen, Valenica, CA, USA) and total RNA was extracted on 
Qiagen RNeasy columns. Nucleic acid concentrations were determined 
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on a Nanodrop Spectrophotometer 2000 (Thermo Scientific, Wilminton, 
DE, USA). Both DNA and RNA exhibited high 260/280 ratios of 1.92 ± 
0.04 and 2.10 ± 0.03, respectively (average ± SD), indicating adequate 
quality for downstream analysis. 
 
mRNA expression arrays 
Commercially available 4x44K zebrafish mRNA expression arrays, 
RNA spike-in kit, and Low Input Quick Amp one-color labeling kit 
(Agilent) were used following manufacturer’s protocols. In brief, cDNA 
was synthesized from RNA and transcribed into cRNA using Cyanine-3 
fluorescent dCTP. Labeled cRNA was purified using a Qiagen RNeasy 
mini kit per the manufacturer’s protocol and quantified on a NanoDrop 
spectrophotometer. Samples with total cRNA yields greater than 1.65 
µg and specific activity greater than 6 pmol Cy3/µg were fragmented, 
hybridized to array slides at 65°C for 17 hours, washed briefly, and 
scanned on an Agilent SureScan array scanner using grid file 
026437_D_F_20140627 and scan protcol AgilentHD_GX_1Color. Data 
were extracted from raw TIFF files using FeatureExtraction software 
(Agilent) and spot brightness values were loaded into R. Raw microarray 
data files and derived expression values are archived at the Gene 
Expression Omnibus (https://www.ncbi.nlm.nih.gov/geo) under 
accession number GSE100583. 
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Data normalization, analysis, and annotation 
Data were cleaned by subtracting background fluorescence, 
normalizing across arrays, and averaging duplicate probes within the 
limma package90 using R91 version 3.3.2. Principal component analysis 
using the prcomp() function within base R (v.3.3.2) was performed 
using cleaned data (center = TRUE, scale = TRUE) and illustrated an 
overlapping, but clear, separation between male and female samples 
(variance explained by PC1 = 18.3% and variance explained by PC2 = 
14.7%; PC1 + PC2 = 33%), so all downstream analysis was performed 
with male and female datasets separated. Within limma, empirical Bayes 
fitting of a linear model and pairwise contrasts were applied to AB, TU, 
and WIK strains separately to test for differences between males and 
females per strain. These results will be referred to as “sex differences”. 
Similarly, a linear model and pairwise contrasts were applied to males 
and females separately to test for differences between AB, TU, and WIK 
per sex. These results will be referred to as “strain differences”. Pairwise 
comparison values for fold change (log-2), average expression (log-10), 
p-value, and q-value were averaged for each strain and centered on 
zero to facilitate data interpretation. Significant probes were defined as 
≥ 2-fold change in expression and Benjamini-Hochberg92 adjusted p-
value ≤ 0.05 (q-value). Standard Agilent array annotations were applied 
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to the probes and manually verified across NCBI and Ensembl 
databases. Conflicting annotations were resolved by direct overlap of 
mapped probes using UCSC’s LiftOver tool as needed. Heatmaps were 
produced using the gplots heatmap.2 tool in R (v.3.3.2). Ordering of 
genes within heatmaps was performed using Euclidean distances and 
complete h clustering without scaling.  
 
Gene ontology analysis 
Gene ontology analysis was performed using the Panther 
Classification Tool93 developed and maintained by the Gene Ontology 
Consortium. Ensembl and NCBI’s ENTREZ gene ID annotations were 
assessed for statistical over-representation in the Danio rerio database 
(ZFIN last updated 04/2015) using default settings. GO complete 
annotations (database released 4/24/2017) for cellular component, 
biological process, and molecular function were assessed with 
Bonferroni94 correction for multiple testing. Genes were considered 
over-represented at q-value ≤ 0.05 and results are presented as fold 
enrichment over the Danio rerio reference database. 
 
Results 
mRNA expression profiles differ between sexes in two of three strains 
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Analysis of total hepatic mRNA expression arrays detected 149 
probes representing 141 genes that are significantly different between 
AB males and females (Figure 3.2A; Supplementary Dataset 3.1). Of 
these, 62 probes have a positive fold change indicating an increased 
expression of the transcript in males relative to females and 87 have a 
negative fold change indicating an increased expression of the transcript 
in females relative to males. Gene ontology analysis of 117 gene IDs 
(82.98%) mapping to Danio rerio shows that differences between males 
and females in the AB strain occur largely at the endoplasmic reticulum 
membrane (6.40-fold enriched, q-value = 3.01 x 10-3). The biological 
processes of response to estradiol (87.14-fold enriched, q-value = 2.03  
x 10-2), cellular response to estrogen stimulus (74.36-fold enriched, q-
value = 1.00  x 10-9), lipid transport (22.49-fold enriched, q-value = 
1.25 x 10-9), small molecule biosynthetic processes (10.46-fold 
enriched, q-value = 8.01 x 10-4), and monocarboxylic acid metabolic 
processes (7.88-fold enriched, q-value = 2.98 x 10-2) are statistically 
over-represented in the dataset and are largely driven by lipid 
transporter activity (29.05-fold enriched, q-value = 3.99 x 10-10) and 
oxidoreductase activity (4.79-fold enriched, q-value = 9.63 x 10-4). 
Between WIK males and females, 72 probes representing 67 
genes are significantly different (Figure 3.2B; Supplementary Dataset 
3.2). Of these, 23 probes have a positive fold change indicating an 
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increased expression of the transcript in males relative to females and 
49 have a negative fold change indicating an increased expression of 
the transcript in females relative to males. Gene ontology analysis of 58 
gene IDs (86.57%) mapping to Danio rerio shows that differences 
between males and females in the WIK strain are not restricted to one 
cellular compartment, but encompass biological processes including 
response to estradiol (>100-fold enriched, q-value = 2.44 x 10-3), 
cellular response to estrogen stimulus (>100-fold enriched, q-value = 
7.38 x 10-8), hormone biosynthetic processes (>100-fold enriched, q-
value = 1.30  x 10-2), and lipid transport (37.80-fold enriched, q-value 
= 5.23  x 10-10). Similar to AB, these over-represented biological 
processes in WIK are largely driven by lipid transporter activity (42.61-
fold enriched, q-value = 3.51 x 10-8). Interestingly, at our cutoff values 
of a minimum of 2-fold change in expression and q-value = 0.05, there 
are no probes that are significantly different between TU males and 
females. This is most likely due to a wider variation in the TU gene 
expression dataset.  
Overlapping the differentially expressed probe sets from both AB 
and WIK produces a set of 40 probes mapping to 36 genes that are 
differentially expressed between males and females, regardless of strain 
(Figure 3.2C; Supplementary Dataset 3.3). Of these, only 6 probes have 
a positive fold change indicating an increased expression of the 
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transcript in males relative to females and 34 have a negative fold 
change indicating an increased expression of the transcript in females 
relative to males. Examples of mRNA transcripts conserved across 
strains include the protein responsible for converting androstenedione 
to testosterone (hsd17b3) in males and an egg yolk precursor (vtg1-7) 




Figure 3.2: Top 20 most significant differentially expressed genes 
between sexes. Positive fold change values indicate higher mRNA gene 
expression in males, as compared to females. Negative fold change 
values indicate higher mRNA gene expression in females, as compared 
to males. A) In AB the top 20 q-values range from 0.0049 to 0.0062. B) 
In WIK the top 20 q-values range from 0.0030 to 0.0150. C) Regardless 
of strain the top 20 q-values range from 0.0081 to 0.0164. Fold change 
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values were averaged between male and female datasets. See 
supplementary datasets 1-3 for gene symbol definitions. 
 
mRNA expression profiles differ between strains 
Within males, 292 probes representing 269 genes are significantly 
different between AB, TU, and/or WIK males (Figures 3.3A and 3.4; 
Supplementary Dataset 3.4). Seventy-three (73) probes varied between 
TU and WIK (AB = 0 fold-change), 117 probes varied between AB and 
WIK (TU = 0 fold-change), and 102 probes varied between AB and TU 
(WIK = 0 fold-change). Within the strains, the percentage of transcripts 
with significantly increased expression accounted for 49.2-62.5% of the 
mRNA transcripts, with a mean of 56.3%. Gene ontology analysis of 237 
gene IDs (88.10%) mapping to Danio rerio shows that differences 
between AB, TU, and/or WIK males are not restricted to one cellular 
compartment or molecular function, but are over-represented by the 
biological process of circadian regulation of gene expression (45.89-fold 
enriched, q-value = 7.20 x 10-3). 
In females, 220 probes representing 212 genes are significantly 
different between AB, TU, or WIK (Figures 3.3B and 3.4; Supplementary 
Dataset 3.5). Fifteen (15) probes varied between TU and WIK (AB = 0 
fold-change), 80 probes varied between AB and WIK (TU = 0 fold-
change), and 125 probes varied between AB and TU (WIK = 0 fold-
change). Within the strains, the percentage of transcripts with 
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significantly increased expression accounted for 57.0-67.5% of the 
mRNA transcripts, with a mean of 60.5%. Gene ontology analysis of 183 
gene IDs (86.32%) mapping to Danio rerio shows that differences 
between AB, TU, and/or WIK females occur largely at the endoplasmic 
reticulum membrane (5.32-fold enriched, q-value = 9.58  x 10-4). 
Biological processes affected include protein targeting to the 
endoplasmic reticulum (49.52-fold enriched, q-value = 5.06 x 10-3), 
membrane assembly (31.28-fold enriched, q-value = 3.07 x 10-2), and 
single-organism metabolic processes (2.50-fold enriched, q-value = 
3.27 x 10-3). These over-represented biological processes are largely 
driven by catalytic activity (1.72-fold enriched, q-value = 4.34 x 10-3). 
Overlapping the differentially expressed probe sets from both 
males and females produces a set of 63 probes representing 59 genes 
that are differentially expressed between AB, TU, and WIK regardless of 
sex (Figures 3.3C and 3.4; Supplementary Dataset 3.6). Six (6) probes 
varied between TU and WIK (AB = 0 fold-change), 29 probes varied 
between AB and WIK (TU = 0 fold-change), and 28 probes varied 
between AB and TU (WIK = 0 fold-change). More than 50% of the 
probes varying between strains, regardless of sex, are attributable to 
the AB strain alone. Within the strains, the percentage of transcripts 
with significantly increased expression accounted for 46.7-56.6% of the 
mRNA transcripts, with a mean of 52.3%. Gene ontology analysis of 52 
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gene IDs (88.14%) mapping to Danio rerio shows no over-
representation of any category between AB, TU, and/or WIK, regardless 
of sex.  
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Figure 3.3: Top 20 most significant differentially expressed genes 
between strains. Positive fold change values indicate an increase in 
mRNA gene expression and negative fold change values indicate a 
decrease in mRNA gene expression. AB is represented by black bars, TU 
is represented by checkered bars, and WIK is represented by white bars. 
A) In males the top 20 q-values range from 0.0003 to 0.0020. B) In 
females the top 20 q-values range from 0.0005 to 0.0014. C) Regardless 
of sex the top 20 q-values range from 0.0007 to 0.0077. See 





Figure 3.4: Differentially expressed mRNA transcript heatmaps. 
Individual heatmaps for males alone, females alone, and shared 
between the sexes (global) across AB, TU, and WIK strains. Blue 
indicates a positive fold change in expression, red indicates a negative 
fold change in expression. Higher saturation indicates stronger positive 
or negative fold change. 
 
Discussion 
A primary goal of this study was to identify baseline liver mRNA 
expression variation between different zebrafish strains. We identified 
large differences between strains, with a majority of differentially 
expressed mRNA transcripts belonging to AB (Figure 3.5). We 
hypothesize that this is due to the additional bottleneck of gynogenesis 
in the early establishment of the AB strain and a resulting decrease in 
heterozygosity by 34%, as similarly observed in gynogenetic diploid 
rainbow trout (Oncorhynchus mykiss)95. Additionally, across all sexes 
and strains, approximately 59% of probes show an increase in 
expression versus a decrease.  The bottleneck of domestication reduces 
genetic variation96, but since there is little to no selection acting on these 
laboratory strains, we predicted wide variation in expression phenotypes 
across strains97 due to the inherent increase in the inbreeding 
coefficient98. Although we have described robust gene expression 
variation between AB, TU, and WIK, laboratory stocks still have less 
diversity between strains when compared to wild-caught zebrafish62. 
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Figure 3.5: Summary chart of highly differentially expressed probe 
count in males or females across strains. Each bar represents a count 
of the mRNA transcripts with 2-fold increased (to the right) or decreased 
(to the left) expression by strain in males (top) and females (bottom) in 
AB, TU, or WIK. AB is represented by black bars, TU is represented by 
checkered bars, and WIK is represented by white bars. 
 
Sex and strain both drive mRNA expression profiles in zebrafish 
Sex determination in zebrafish has been argued extensively in the 
last decade, but only recently has a six-strain analysis led to a 
consensus hypothesis. Our current understanding is that genetic factors 
on chromosome 4 drive the ZW/ZZ sex-determining mechanism, but 
ultimate sex determination is sensitive to multiple environmental 
conditions99. Fascinatingly, AB and TU strains appear to have lost sex-
specific signal across the sex-associated region in chromosome 4, so 
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factors defining male or female development in these strains are still 
unknown. WIK retains the chromosome 4 sex-associated region and has 
additional regions on chromosome 14 and several unassembled genomic 
scaffolds that are associated with sex determination. Interestingly, 
principle component analysis uncovers male and female grouping, as 
well as a clear separation of AB away from TU and WIK (Figure 3.6). 
Although sex is a major factor in this dataset, the loss of sex-
determining regions in AB and TU do not appear to be driving the 
difference in mRNA expression between strains. Interstrain variation is 
most likely due to genetic differences caused by population isolation and 
bottleneck events during strain establishment. Moreover, we observed 
a large portion of differentially expressed mRNA transcripts that were 
specific to the AB strain, probably due to the extreme population 
bottlenecks and multiple rounds of gynogenesis. 
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Figure 3.6: Principle component analysis of samples by sex or strain. 
PC1 and PC2 explain 33% of the total variance in the dataset. Sample 
identification by sex shows that male and female samples segregate, 
with the exception of a single female sample. Sample identification by 
strain shows that the AB strain clearly segregates from the TU and WIK 
strains. 
 
Lipid transport mRNA transcripts differ between sexes in multiple strains 
Genes involved in lipid transport are significantly enriched in 
differentially expressed mRNA transcripts between males and females 
in both AB and WIK. Among these are members of the vitellogenin 
(vtg1-7), retinol binding protein (rbp2a and rbp5), and solute carrier 
(slc27a6 and slc25a48) families, as well as a transmembrane trafficking 
protein (tmed1a), a kainite glutamate receptor (grik1a), and an 
estrogen receptor (esr1). It is important to accurately characterize these 
differences between strains because lipid transport is critical in chemical 
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messaging, energy storage, temperature maintenance, and formation 
of membranes, cholesterol and prostaglandins. Furthermore, 
vitellogenin is a common marker for endocrine disruption in teleosts; 
any variation between expression in this endpoint may drastically affect 
interpretation of pharmacological endpoints including estrogenic activity 
of xenobiotics. 
 
Circadian rhythm affects mRNA expression in males more than females 
Circadian regulation in the zebrafish is directed by light- or dark-
induced gene expression in the pineal gland100. Although our study 
design did not control for time of day (AB livers were collected in the 
morning, while TU and WIK livers were collected in the afternoon), there 
are only a small number of genes with circadian rhythm annotations. 
Specifically, we identified 295 annotations to 67 genes by searching 
AmiGO2101 annotations for any term including the word “circadian” 
within zebrafish annotations. In the male dataset there are 6 genes that 
annotate to circadian rhythm: arntl1a, bhlhe40, cry5, nfil3-5, nfil3-6, 
and nr1d2a. In the female dataset there are only two genes that 
annotate to circadian rhythm: arntl1a and cry5.  
To expand our analysis of potential circadian effects on our 
dataset, we queried circadian rhythm genes annotated in all organisms 
within AmiGO2. This expanded our list of potential circadian rhythm 
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genes to 2194, but led to no additional genes for the male dataset, and 
added only one gene, F7, to the list of genes present in female dataset 
that are known to be influenced by circadian rhythm. F7 has been 
observed to be regulated by circadian rhythm in the Norway rat102 and 
C57BL/6J mouse103, but a similar regulation has yet to be identified in 
zebrafish. Using a comparable approach, we queried a circadian rhythm 
RNA-seq dataset in Mus musculus that assessed gene expression in 
multiple tissues across time104. We found 9 genes—bhlhe41, ptgr1, 
dnaja4, fads2, fkbp5, lmbr1l, nedd41, slc38a4, and stk35—in the mouse 
circadian rhythm dataset, but as of yet there is no clear evidence of 
oscillation in the expression of these genes in the liver of zebrafish. 
Again in this vein of inquiry, we queried the circadian expression profiles 
data base (circaDB)105 against 4 mouse liver microarray studies and 
found 82 genes that have evidence of circadian regulation 
(Supplementary Dataset 3.7). 
Expression patterns for the two circadian genes that are shared 
between males and females are conserved, with a decrease in 
expression of arntl1a and an increase in expression of cry5 in the AB 
strain as compared to TU and WIK. This can be explained by the timing 
of liver harvest (AB in AM; TU and WIK in PM). What is fascinating, 
though, are the other genes affected by circadian rhythms that differed 
in the WIK strain only. Bhlhe40 had lower expression in WIK and nfil3-
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5, nfil3-6, and nr1d2a had higher expression in WIK. If expression of 
these genes were solely driven by circadian rhythms, then we would 
expect to see similar patterns between TU and WIK. Because this 
relationship is lacking, we hypothesize that there are other genetic 
factors that regulate the expression of these genes that differ between 
strains. This is interesting because experimental design accounts for the 
differences in males, but females seem to be less sensitive, suggesting 
that males are more sensitive to circadian perturbation than females. 
This is not unfounded as sex-specific phenotypes related to circadian 
rhythm have been observed in several animals, including behavioral 
traits in Drosophila106 and liver metabolism in mice107. Most circadian 
oscillations in gene expression are not conserved across tissues and 
there are transcriptional “rush hours” prior to dawn and dusk104. Our 
samples were collected starting at 4 hours after dawn and ended 3 hours 
prior to dusk, which avoids the transcriptional rush hour and minimizes 
the maximal effects of circadian-driven transcription. Nonetheless, this 
is a reminder that time of day is a factor that should be considered in 
zebrafish study design, but that it is not the dominant driver of overall 
gene expression.  
 
Functional implications of gene expression variation 
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While this is solely a descriptive study on the standing variation 
that exists in three strains of zebrafish, there are functional 
consequences of variable mRNA expression that should be assessed for 
the continued application of zebrafish as a model system. For example, 
in this dataset AB males have a greater than expected number of serine-
type endopeptidase (GO:0004252) mRNA transcripts: prss59.1, 
prss59.2, ela2l, try, and cela1. All of these genes have greater than 7-
fold lower expression in AB as compared to TU or WIK. Loss of 
expression of these genes in AB males may indicate a reduction in their 
ability to break internal amino acid bonds within polypeptide chains. As 
another example, WIK males have greater than 7-fold higher expression 
of two presynaptic membrane assembly (GO:0097105) mRNA 
transcripts:  nlgn3a and cel.2. Both of these genes are involved in 
neuron cell-cell adhesion and neurexin family protein binding. Neuroligin 
genes, such as nlgn3a, are important in zebrafish nervous system 
development108. Disruption of the neurexin pathway at synapses leads 
to autistic-like behavior in mice109 and mutation in nlgn3a in humans 
was associated with x-linked Asperger and autism disorders110. 
Moreover, a zebrafish model for autism spectrum disorder displays 
behavioral differences between strains66. cel.2 is associated with 
maturity-onset diabetes of the young, type 8, with exocrine 
disfunction111. Because WIK males exhibit higher expression of these 
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genes, they may be compensating for loss of expression of related 
genes. A functional follow-up would be to see if neuronal synapses are 
enriched in WIK males for neurexin receptors or if there are any 
behavioral or exocrine disruption as compared to AB or TU males.  
As a final example, AB have an 8-fold decrease in si:dkeyp-73d8.9 
mRNA expression, an unknown transcript, in both males and females. 
Protein-protein alignment of the predicted amino acid sequence for 
si:dkeyp-73d8.9 against NCBI’s non-redundant protein sequence 
database indicates that this is most likely a cystatin-like protein. 
Cystatins are inhibitors of cysteine proteinases and play a role in 
tumorigenesis, kidney function, and modulation of the immune 
system112. If all AB fish lack expression of this gene, then AB may be a 
better strain to target for development of mutation strains for model 
diseases involved in the disruption of the cystatin pathway. Continuation 
of describing and validating variation within zebrafish is paramount to 
the expansion of the zebrafish model system. This will further elevate 
the relevance of zebrafish studies to human health through the 
incorporation of multiple strains to simulate wide population variances, 




Our current understanding of zebrafish as a genetic model is 
based on the reference genome, which has only included alternate 
sequence loci as of June 2017113. The addition of alternate loci is a 
pivotal achievement for zebrafish as a model because it allows the 
interpretation of datasets with wide variance due to underlying structure 
within the data, such as genetically distinct sub-groups or populations. 
Our study goes one step further by describing baseline mRNA expression 
differences between zebrafish strains as a physiological interpretation of 
established genetic differences between zebrafish strains. We found 
major differences between strains and sexes including lipid transport 
and circadian rhythms. In the absence of a practical understanding of 
intra-population baseline variation, the downstream interpretation of 
data becomes skewed, reproducibility becomes increasingly challenging, 
and the application of study results become more abstract. Thus, this 
study serves as a foundational comparison of the strain-specific 
variation in mRNA expression in zebrafish and should be used to inform 
future study designs. 
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Response eQTL analysis of low-dose PCB exposure connects 
genomic copy number variants to susceptibility 
Under review for publication in Aquatic Toxicology 
 
Abstract 
Physiological variation induced by genomic copy number variants 
(CNV) have received tremendous attention in human disease research, 
but little work outside of human health has be conducted. Herein we 
assess variable toxicant susceptibility phenotypes in zebrafish (Danio 
rerio), using microarrays to identify genomic copy number variants 
associated with induced gene expression differences. A micro-exposure 
approach (on the ng/L scale) was utilized to uncover secondary sex-
specific mechanisms of PCB-126 toxicity without over-inducing the 
transcriptionally dominate cytochrome P450 family of xenobiotic 
metabolizing enzymes. We found over 30,500 CNV across all individuals, 
with approximately 3% of those CNV present at a frequency of ≥ 0.80 
per strain. Following 24 hours of 130 ng/L PCB-126 exposure, we found 
124 differentially expressed mRNAs in females and 97 differentially 
expressed mRNAs in males. Using identified CNV with high penetrance 
and PCB-126 induced mRNA expression data, we identified two sex-
specific response eQTL, one each in males and females, for this 
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phenotype using a linear model analysis. The male response eQTL 
involves pre-mRNA processing factor 4 (prpf4) and the female response 
eQTL involves dynein cytoplasmic 2 heavy chain 1 (dync2h1). The CNV 
in both response eQTL are gains, but the response of the mRNA in each 
case differs. In prpf4, mRNA expression decreases when fish are 
exposed to PCB-126 while dync2h1 mRNA expression increases 
following exposure. This is the first time that either of these genes have 
been linked to the PCB-126 susceptibility phenotype and both fall 
outside the canonical xenobiotic response pathway. Regardless, either 
or both may be linked tangentially with aryl hydrocarbon nuclear 
translocator transcriptional response elements. 
 
Introduction 
Genetic variation is the cornerstone for building stable populations 
resilient to environmental and ecological change. In sexually 
reproducing species, gene flow arising from immigration, emigration, 
mutation, and drift maintain genetic variation across populations from 
which natural selection determines “winners and losers”. Among most 
studied species, the primary genetic research efforts have focused on 
variation arising due to single nucleotide polymorphisms (SNPs) or small 
insertions and deletions (indels). SNPs and indels can alter phenotypes 
by causing changes in the rate of transcription or changes in translated 
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protein sequence. Another, and perhaps more important, source of 
genetic variation is genomic structural variation, such as copy number 
variants (CNV) and inversions, which have been shown to modify 
phenotypes by altering gene expression114. Despite their large size and 
widespread genomic locations, CNV have received much less research 
attention115. A recent comprehensive study using matched DNA and 
tissue-specific mRNA expression from the Genotype-Tissue Expression 
(GTEx) consortium found that structural variants have larger effects 
compared to SNPs and indels, and primarily act via noncoding sequence 
variants localized to gene enhancer regions and regulatory elements19. 
To interrogate the effect of CNV on complex traits, we utilized a 
zebrafish (Danio rerio) model of toxicant susceptibility. The zebrafish 
toxicant model is comprised of genetically distinct laboratory strains4 
which exhibit a wide range of susceptibility to PCB-126 (3,3',4,4',5-
Pentachlorobiphenyl), having developmental toxicity ranging from 9-
336 ppb across six strains44, and abundant strain-specific CNV46. While 
several SNPs, including one located within the primary ligand-target 
(aryl hydrocarbon receptor, AHR), have been associated with the PCB-
susceptibility phenotype44, no study to date has addressed the role of 
CNV for this trait. Toxicant susceptibility and resistance phenotypes are 
known to be conserved across mammals, birds, fish, frogs, and 
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invertebrates, but manifest through multiple mechanisms116, making 
this trait an interesting target to query for CNV effects.  
Animals exposed to PCB-126 have increased oxidative damage via 
DNA adducts of 7-hydro-8-oxo-2'-deoxyguanosine (8-oxodG)117, which 
are generally repaired by the base excision repair pathway118. If adducts 
are not repaired prior to DNA replication, there is an increased likelihood 
for double strand breaks119 and errors in double strand break repair is 
one mechanism by which CNV originate120. To circumvent somatic 
induction of CNV, this study utilizes a micro-dose acute exposure 
experimental design aimed to induce a xenobiotic response while 
avoiding de novo CNV production, as well as other detrimental effects 
that have been well-described with PCB-126, including developmental 
cardiotoxicity121. Our micro-dosing paradigm in adult zebrafish aims to 
elucidate potential alternative mechanisms that may contribute to 
observed differences in PCB-126 susceptibility outside of this pathway.  
Many studies perform exposures in the microgram per liter range 
(generally, 1-1000 ug/L), but negative effects of PCB-126 have been 
reported down to 30 ng/L57. By targeting exposures well below the 
common ranges observed in zebrafish studies, we aim to uncover 
secondary mechanisms outside of the AHR response pathways. Our goal 
is to avoid the transcriptionally dominant induction of the cytochrome 
P450 family of xenobiotic metabolizing enzymes122, while conserving the 
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real-world relevance of low-dose PCB exposure. The United States 
Center for Disease Control reports that the geometric mean of PCB-126 
in the U.S. population is 16.3 pg/g of lipid (from serum samples)56, while 
zebrafish exposed for 48 hours to PCB-126 at 3 ug/L have a body load 
of 37.2 ug/g of lipid (from whole embryo homogenates)57. Taken 
together, these points indicate that assessment of PCB-126 effects at 
higher concentrations is inadequate for understanding the effects of 
human PCB exposure and that our micro-dosing model may be better 
for elucidating the genetic determinants of PCB-126 susceptibility across 
populations from the human health perspective. 
Finally, due to its lipophilic nature, PCB-126 will preferentially 
sequester to lipid-rich tissue123. Although lipids are largely equivalent 
between the sexes, males have higher liver and gonad lipid content than 
females124 indicating that sex may act as a modifying factor in the 
variable effects of PCB-126 exposure. Studies in aquatic model 
organisms have used embryos and larvae due to easily observable 
developmental toxicity induced by PCB-126 exposure. The gold standard 
used to identify sex in zebrafish is by visual inspection of gonads 
because there are currently no reliable genetic markers for sex. 
Moreover, because zebrafish are juvenile hermaphrodites until sexual 
differentiation at 6 weeks125,126 and because identification of sex in the 
exposed larvae is not possible by genetic means, sex-specific factors 
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have not been identified in early life stage exposures. For these reasons, 
we chose to use sexually mature adult zebrafish to assess the role of 
sex on PCB-126 susceptibility in our micro-dosing experiment.  
 
Materials and Methods 
Zebrafish Care and Aquatic Exposures 
All procedures were approved by the Portland State University 
Institutional Animal Care and Utilization Committee in accordance with 
the Office of Laboratory Animal Welfare’s Public Health Service policy. 
The zebrafish aquatic facility at Portland State University is composed 
of a recirculating flow-through housing system (Aquaneering). Water 
temperature is maintained at 28.5°C with average pH of 7.4, average 
conductivity of 1100 uS, and a 14:10 hour light:dark cycle. Zebrafish 
are fed flake food (Tetra) twice daily and supplemented with artemia 
and/or rotifers depending on life stage. 
Three strains of zebrafish (AB, Tuebingen (TU), and WIK; 
n=6/strain/treatment; ntotal=54) locally maintained for four generations 
were exposed to three treatments: 1) 130 ng/L 3,3’,4,4’,5-
pentachlorobiphenyl (PCB-126; Ultra Scientific), 2) 20 ppm (v/v) 
acetone127 as a vehicle control, or 3) nothing (naïve). We chose 130 
ng/L as our exposure dose because it falls within the range of doses 
known to cause sublethal effects in embryos57 and to avoid excessive 
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induction of oxidative DNA lesions117. Exposures were performed 
statically in 4 L glass beakers for 24 hours, zebrafish were fasted for the 
duration of the exposure, and at the end of the exposure period 
zebrafish were humanely euthanized for liver and muscle tissue 
collection. Tissues were flash frozen in liquid nitrogen and individuals 
were confirmed as male or female by visual inspection of gonadal tissue. 
 
Nucleic Acid Extraction and Quantification 
DNA was extracted and isolated from white muscle tissue using a 
Qiagen DNeasy Blood & Tissue kit per the manufacturer’s protocol. RNA 
was extracted and isolated from liver tissue using a Qiagen RNeasy Mini 
Kit per the manufacturer’s protocol. DNA and RNA concentration was 
measured using a NanoDrop 2000 (Thermo Fisher Scientific) to obtain 
260/280 absorbance ratios for DNA = 1.96 ± 0.04 (mean ± SD) and 
RNA = 2.09 ± 0.02, indicating that nucleic acid preps were of high 
quality for downstream analysis. Archived DNA from Casper strain 
zebrafish128 was used as a reference pool of DNA for CNV genotyping. 
 
Phenotyping by mRNA Expression Microarray 
100 ng extracted total RNA and control RNA (Agilent RNA Spike-
In Kit, One-Color) was labeled following the manufacturer’s protocol 
(Agilent RNA Spike-In Kit, One-Color and Agilent Low Input Quick Amp 
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Labeling Kit). Briefly, cDNA was synthesized then cRNA was synthesized 
from the cDNA template and concurrently labeled with cyanine 3-CTP 
(cy3) dye. Labeled cRNA was purified (Qiagen RNeasy Mini Kit) and 
quantified on a NanoDrop 2000. Only labeled samples with a yield of ≥ 
1.65 ug total cRNA and specific activity of ≥ 6 pmol cy3/ug total cRNA 
were hybridized to arrays. 
Labeled samples plus a blocking agent (Agilent) were fragmented 
for 30 minutes on a 60°C heat block, loaded onto each gasket well, 
sealed, and hybridized at 65°C for 17 hours at 10 RPM to Agilent 4x44K 
Zebrafish (V3) Gene Expression microarrays. After incubation, arrays 
were washed and scanned immediately on an Agilent SureScan 
microarray scanner. Data were extracted from arrays using Agilent 
Feature Extraction software and assessed for basic quality control 
parameters included in the standard Feature Extraction QC report. After 
passing quality control requirements data were cleaned and loaded into 
R91 (v.3.3.2).  
Differential expression was determined using the limma 
package90. The cyclic loess method was used for inter-array 
normalization and replicate probes were averaged within arrays. Males 
and females were separated into sex-specific datasets to avoid the 
effects of transcriptional differences between sexes129. Pairwise 
comparisons were made between strains in the PCB and naïve groups 
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after controlling for effects of the vehicle control (PCB minus vehicle). 
Differential expression was defined as any probe with a Benjamini-
Hochberg corrected p-value92 (q-value) ≤ 0.05. 
 
Genotyping by Copy Number Variant Microarray  
1 ug extracted DNA or archived Casper DNA was labeled using the 
BioPrime Array CGH Genomic Labeling System (Invitrogen) and 
fluorescent cy3 or cyanine 5-CTP (cy5) dyes (Perkin Elmer) following 
the manufacturer’s protocol. Briefly, DNA was fragmented on a 
thermocycler at 95°C for 30 seconds to a target size of 200-500 bp, 
reference DNA (Casper) was labeled with cy3, test strain DNA (AB, TU, 
or WIK) was labeled with cy5 dye, labeled DNA was cleaned using 
Amicon Ultra filter columns (Millipore), and quantified on a NanoDrop 
2000. Target parameters for labeled samples were a yield of ≥ 2.8 ug 
labeled DNA (equation 4.1) and specific activity of 20-60 (equation 4.2). 
 
Equation 4.1: 






∗ 1000 = 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 
 
Labeled samples were combined, denatured, prehybridized with 
50 ug herring sperm to block excessive hybridization across hyper-
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repetitive regions, and hybridized on custom designed 1M aCGH arrays 
designed to span the danRer7/Zv9 zebrafish reference genome (Agilent) 
at 65°C for 40 hours at 20 RPM. After incubation, arrays were washed 
and scanned immediately on an Agilent SureScan microarray scanner. 
Data were extracted from arrays using Agilent Feature Extraction 
software and assessed for basic quality control parameters included in 
the standard Feature Extraction QC report. After passing quality control 
requirements data were cleaned and loaded in to Agilent Genomic 
Workbench 7.0.  
To preprocess arrays, data were passed through a feature filter 
(DefaultFeatureFilter which removes saturated and non-uniform 
probes), an aberration filter (minimum number of probes per 
amplification or deletion = 3, minimum absolute average log ratio for 
amplifications = 0.33, minimum absolute average log ratio for deletions 
= 0.5), normalized (legacy center, threshold = 6, bin size = 10, and GC 
correction with a 2 Kb window size), and intra-array replicates were 
combined. Copy number variant regions were called using the 
aberration detection method 2 (ADM-2) algorithms (threshold = 6) 
within Genomic Workbench. ADM-2 incorporates quality information 
about each log ratio measurement, identifies all aberrant intervals per 
sample using high and low log ratios with p-value ≥ 0.05, and 
determines optimal size of aberrations. The strength of the ADM-2 
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algorithm is its ability to incorporate noisy data and identify small 
aberrant regions. CNV calls were processed through a custom perl script 
(DataMerge2) using a 50% reciprocal overlap across CNV regions to 
identify a copy number gain or loss and regions of 50% overlap (with 
shared parents) within CNV46.  
Not all CNV are present in all individuals16. Because the PCB-
susceptibility phenotype is strain-specific, we assume that CNV that may 
be involved in this trait are present at a high frequency within each 
strain. Operating under this assumption, we assessed the strain-specific 
frequency of CNV and only included high frequency variants (frequency 
≥ 0.8) for expression QTL (eQTL) analysis. 
 
eQTL Identification and Response eQTL Confirmation 
To identify eQTL we applied a linear model that uses CNV present 
at a frequency ≥ 0.80 (15/18) in at least one strain as a predictor 
variable and PCB-induced mRNA expression as the response variable.  
Specifically, data were loaded into R as four files:  CNV genotype per 
individual, mRNA expression per individual, start/stop sites for CNV, and 
transcription start site for differentially expressed genes,. eQTL were 
called using the R package matrixEQTL130. This study utilized a linear 
model within matrixEQTL and set cis distances as 2 Mb up- or down-
stream of identified loci. Significance thresholds for cis and trans eQTL 
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were defined using a conservative Bonferroni-corrected p-value94 based 
on the number of comparisons in each group (p-value = 10-4 and 10-8, 
respectively).  
Because our linear model only incorporated mRNA expression 
from PCB-exposed individuals, we did additional data visualization to 
confirm that the transcriptional response differed with CNV status (as 
identified by the eQTL association) and differed in PCB-exposed 
individuals as compared to naïve or vehicle-exposed individuals. To 
confirm the PCB-specific response of statistically significant eQTL we 
plotted the eQTL we had identified by treatment, strain, and CNV status 
to look for treatment-specific differences in gene expression131. 
 
Results 
PCB-mediated differential gene expression among strains 
Baseline comparison between strains revealed differential 
expression of 1539 probes in males and 2610 probes in females. 
Assessment of the effect of PCB exposure resulted in statistically 
significant (BH-corrected p-value < 0.05) up- or down-regulation of 
expression of 249 probes in males and 831 probes in females. Of these 
differentially expressed probes, only 97 in males (38.96%) and 124 in 
females (14.92%) remained after removing probes that were 
significantly different between strains before treatment or significantly 
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Figure 4.1: Heatmaps of female and male samples indicating relative 
mRNA expression induced by 24 hours of PCB-126 exposure. There are 
124 probes with significantly differential expression in females and 97 
probes in males. Yellow indicates a decrease in expression relative to 
naïve controls, blue indicates an increase in expression relative to naïve 
controls, and black indicates no change. Probes are organized by 
similarity of expression pattern, as determined by Euclidean distance 
and complete linkage. 
 
CNV Frequency within Strains 
Although microarrays can identify CNV, they are unable to 
determine if the variant regions are somatic (de novo) or within the 
germline. Because this study aims to identify germline CNV that are 
unique across strains, but conserved within strains, we assessed CNV 
for frequency by strain to identify targets for eQTL analysis (Table 4.1). 
Distribution of CNV throughout strains varied widely, with only 7.91% 
of CNV (2418/30587) with a strain-specific frequency ≥ 0.50 and only 
0.94% of CNV (287/30587) with a strain-specific frequency of 1.00.  Of 
the 2.93% of CNV occurring in at least 15 out of 18 individuals per strain 
(frequency ≥ 0.80), we identified 200 unique CNV gains and 381 unique 
CNV losses across AB, TU, and WIK strains relative to the reference 
strain. 
 
Table 4.1: CNV counts per frequency threshold where frequency = # 
individuals with CNV/total # of individuals, calculated across strains 
independently (AB, TU, WIK).  CNV gain or loss is relative to Casper 
reference strain. Total indicates number of CNV present in single or 
multiple strains, but only counted once. 
85 
 
frequency   0.50  0.80  1.00 
CNV   gain loss  gain loss  gain loss 
AB  322 618  65 164  16 34 
TU  1220 419  423 94  181 25 
WIK  279 120  127 141  24 30 
total  1414 1004  514 381  200 87 
 
Cis and trans eQTL driving PCB-susceptibility phenotype 
Two cis eQTL were identified in males and one cis eQTL was 
identified in females that associate a CNV with a gene that is 
differentially expressed between strains (Figure 4.2). The first male 
eQTL, prpf4+CNV_155, associated expression of pre-mRNA processing 
factor 4 (prpf4) mRNA with CNV_155 (chr5:60447537-60600000, 
danRer7/Zv9) with an effect size of -0.32 and a false discovery rate of 
0.0004. The second male eQTL, XM_001919485+CNV_717, associated 
expression of XM_001919485 (filamin-a, flnb) mRNA with CNV_717 
(chr11:43264797-43262726, danRer7/Zv9) with an effect size of 0.22 
and a false discovery rate of 0.002.  Finally, the female eQTL, 
dync2h1+CNV_343, associated expression of dynein cytoplasmic 2 
heavy chain 1 (dync2h1) mRNA with CNV_343 (chr15:43913087-
43913146, danRer7/Zv9) with an effect size of 0.37 and a false 
discovery rate of 0.005.  Relative expression levels and CNV status 
across each eQTL are indicated in Table 4.2. Of these, the eQTL 
containing CNV_717 did not show any expression differences in 
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response to PCB-exposure and was therefore not deemed a true 
response eQTL (reQTL). 
 
 
Figure 4.2: eQTL plots showing CNV status on the x-axis (loss, no 
change, or gain) and mRNA expression level on the y-axis for three 
statistically significant eQTL. Colors indicate strain type (AB = green, TU 
= blue, WIK = orange); symbol indicates treatment (empty circle = 
naïve, circle with x = vehicle control, full circle = PCB-126). 
 
Table 4.2: cis eQTL including gene expression and copy number status. 
Gene expression values are relative across strains. Copy number status 
indicates direction of copy number distribution as compared to the 
reference strain, Casper. P-values are unadjusted. 
 
 Gene expression Copy number status  
eQTL AB TU WIK AB TU WIK p-value 
prpf4 
+CNV_155 

























Further inspection of reQTL prpf4+CNV_155 placed the CNV 
region 1.56 Mb downstream of prpf4 (Figure 4.3) and identified a genic 
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region within the CNV (tmem136b). There was no significant differential 
expression of tmem136b, either in naïve controls or PCB-126-treated 
zebrafish. Additionally, we identified 20 xenobiotic response elements 
(XRE, defined as KNGCGTC29) within CNV_155. Associated regions in 
reQTL dync2h1+CNV_343 were much closer; CNV_343 was only 0.67 
Mb upstream of dync2h1. No genic regions and only a single XRE are 
located within the CNV region. 
 
 
Figure 4.3: Two PCB-sensitivity reQTL identified as a) prpf4+CNV_155 
(Chr5:60447537-60600000, Zv9/danRer7) where there is a copy 
number gain in TU males and associated reduction in prpf4 mRNA 
expression following PCB exposure and b) dync2h1+CNV_343 
(Chr15:43189812-43224569, Zv9/danRer7) where there is a copy 
number gain in AB females and associated increase in dync2h1 mRNA 
expression following PCB exposure.  
 
Discussion 
To our knowledge, this is the first study using a micro-dosing 
approach to identify sex-specific mechanisms in the conserved PCB-
susceptibility phenotype. Previous studies have over-looked sex-specific 
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mechanisms, but the reQTL identified in this study point to two 
mechanisms responsible for the variability in PCB-126 susceptibility 
across populations that are specific to either males or females. We found 
prpf4+CNV_155 to be the male-specific mechanism responsive to PCB 
exposure. prpf4 facilitates proper spindle assembly during mitosis by 
recruiting checkpoint proteins at the kinetochore and loss of prpf4 
results in increased aneuploidy and improper mitosis132. prpf4 is a 
member of the spliceosome133, but a study in patients with retinitis 
pigmentosa found that approximately 50% of prpf4 protein was not 
associated with the spliceosome complex134, pointing to other unknown 
functions of this gene.   
Additionally, prpf4 is associated with heat stress in catfish135 and 
ischemic stress in male rats136, so being involved in an exposure-
induced stress mechanism is a reasonable conclusion. An increase in 
copy number of a region enriched for XRE, such as CNV_155, should 
theoretically increase recruitment of transcription factor to that genomic 
location, but male TU zebrafish have a significantly lower expression of 
prpf4 mRNA when exposed to PCB-126 and are more susceptible to the 
toxic effects of PCB than the other strains tested. We hypothesize that 
PCB-induced levels of prpf4 mRNA are reduced in TU due to either an 
overactive post-transcriptional or post-translational regulatory 
mechanism or by physical blockage of the transcription of prpf4 due to 
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recruitment of XRE binding factors. Loss of prpf4 may affect PCB-126-
induced cellular stress through alternate splicing or by a currently 
unknown surrogate function, and therefore result in higher sensitivity to 
PCBs. 
The gene associated with the female-specific reQTL identified in 
this study, dync2h1, is known to be involved in both aminoglycoside137 
and temozolomide138 resistance. Additional support for the role of 
dync2h1 in PCB-126 resistance is that it is localized to the golgi 
apparatus139 where lipids are packaged into vesicles140.  In a 30-day 
zebrafish dosing study at 150 ng/L, the bioconcentration factor (uptake 
rate constant/clearance rate constant) of PCB-126 per animal wet 
weight was 105.81 141, illustrating that the bioaccumulation potential for 
PCB-126 is high due to lipid partitioning.  
AB female zebrafish have an increased copy number of CNV_343 
and a concomitant increase in expression of dync2h1 following exposure 
to PCB-126. AB zebrafish are also more resistant to PCB-126 than the 
other strains tested. Because PCBs are lipophilic compounds, differences 
in packaging and transport of lipids may alter the deposition, 
metabolism, and excretion of PCBs. This suggests that increased 
packaging and transport of PCBs drives PCB-resistance in AB zebrafish.  
Interestingly, both prpf4 and dync2h1 have aryl hydrocarbon 
nuclear translocator (ARNT) transcription factor binding sites within 
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their enhancer regions (as identified by GeneHancer142). ARNT is a well-
described member of the canonical aryl hydrocarbon receptor (AHR) 
PCB-response pathway responsible for transporting ligand-activated 
receptors to the nucleus to directly act as transcription factors143,144. So 
although these two genes have not been previously implicated in PCB-
mediated toxicity, they may be linked to the AHR-mediated PCB-
exposure response mechanism through interaction with ARNT. 
 
Conclusion 
This study identified two novel reQTL associated with population-
specific PCB-sensitivity using microarray-based CNV and mRNA 
expression data. We found two sex- and strain-specific expressed 
targets, namely prpf4 in males of the TU strain and dync2h1 in females 
of the AB strain, proximal to CNV regions that each explain 
approximately a third of the variation of the observed expression 
phenotype. Genetic mechanisms, such as SNPs across the AHR family 
in the Atlantic killifish38, have been shown to drive population-specific 
resistance to PCBs, but this is the first time that genomic copy number 
has been implicated with this trait. Additionally, micro-dose exposure to 
PCB-126 allowed us to interrogate secondary mechanisms outside of the 
traditional AHR-mediated xenobiotic metabolism pathway and identify 
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novel targets that may act in concert with or independent from 
traditional response pathways. 
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Targeted CRISPR-Cas9 Editing of Genomic Copy Number 
Modulates PCB-Susceptibility Phenotype 
 
Abstract 
PCBs are ubiquitous legacy chemicals that cause health effects in 
humans and wildlife. There are several examples of PCB-resistance 
between wild populations living in highly contaminated environments 
versus clean environments, illustrating an adaptive advantage for 
populations that can maintain health in contaminated environments. 
Studies in natural populations that have evolved PCB-resistance 
identified multiple mechanisms—including SNPs, indels, and fusions—
across the aryl hydrocarbon receptor (AHR) as one of the drivers of the 
PCB-susceptibility phenotype. Zebrafish also have variable sensitivity to 
PCB-126 across common laboratory strains making them a unique 
model system to test the genomic drivers of the PCB-susceptibility 
phenotype. A recent study identified genomic copy number across non-
AHR regions to associate with the PCB-susceptibility phenotype. Herein 
we test the effect of copy number on PBC susceptibility by targeting 
duplicated genomic regions in two strains of zebrafish with variable PCB 
susceptibility (AB strain = resistant, Tuebingen (TU) strain = sensitive) 
using CRISPR-Cas9 mutagenesis. Because the CNV in AB zebrafish 
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appears to provide protection from the toxic effects of PCB-126, we 
expect that CRISPR-mutant (crispant) AB zebrafish will show higher 
sensitivity to PCB-126. Conversely, the CNV in TU zebrafish associates 
with increased sensitivity, so we expect crispant TU to have higher 
resistance to PCB-126. To test this we injected 1-cell stage embryos 
with CRISPR-Cas9 ribonucleic protein complexes targeted to strain-
specific copy number variable regions (CNV_343 in AB and CNV_155 in 
TU), exposed embryos to variable concentrations of PCB-126, and 
assessed developmental toxicity by heart rate, edema, and morphology. 
In support of our hypothesis, crispant AB zebrafish showed a reduction 
of EC50 values by a factor of 10, from 627.7 to 67.9 ppb PCB-126, as 
compared to sham-injected controls. Crispant TU zebrafish had slightly 
increased EC50 values, from 35.3 to 47.0 ppb PCB-126, as compared to 
sham-injected controls. This study shows clear evidence of CNV as 
drivers of the PCB-susceptibility phenotype and is a first step towards 




Polychlorinated biphenyls (PCBs) are aromatic hydrocarbons that 
were largely used as insulators, coolants, and plasticizers since their 
commercial inception in the 1930s. In 1979 the United States 
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Environmental Protection Agency banned the manufacture of PCBs due 
to evidence of bioaccumulation, ecological toxicity, observed health risks 
following occupational exposures, and a large-scale incident in Yusho, 
Japan where over 1000 people were poisoned following consumption of 
contaminated cooking oil (reviewed in 53). Although manufacture of 
PCBs was banned in 1979, PCBs are still present in human serum at 
concentrations of 16.3 ± 1.6 pg/g or ppt (geometric mean ± 95% 
confidence interval) on a lipid-weight basis as measured by a 2000-2004 
population survey in the United States56. Current exposure to PCBs is 
mostly through consumption of PCB-contaminated fish, dairy, and meat 
or exposure to PCB-contaminated air or water145 which can result in 
various health effects such as decreased neonatal thymus size146, 
reduced male fertility147, and liver damage148. 
In nature, several examples of the rapid evolution of a PCB-
resistance phenotype have been observed in species living in highly 
contaminated environments, such as the Atlantic killifish (Fundulus 
heteroclitus) in Superfund sites in New Bedford Harbor36 and the Hudson 
River32. Zebrafish (Danio rerio) also exhibit PCB-resistant phenotypes 
that are graded across common laboratory strains; some strains are 
resistant to PCB exposure and others are extremely sensistive44. 
Reports of the genetic mechanisms behind PCB resistance have 
identified alterations to the canonical target of PCB, the aryl 
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hydrocarbon receptor (AHR)39,44,47, by single nucleotide polymorphisms 
(SNPs), short insertions or deletions (indels), or splicing of AHR paralogs 
as the major mechanisms involved in this phenotype, but a substantial 
percentage of the phenotypic variation is not ascribable to short nucleic 
sequence variations in AHR.  
An additional type of genomic variation that has been largely 
overlooked is copy number variation. Copy number variants (CNV) are 
large genomic duplications or deletions, generally on the order of 1 kb 
to 1 Mb. CNV span more of than genome than SNPs15, act mainly 
through direct interaction with regulatory elements, and have a larger 
effect size than SNPs and indels when altering gene expression19. 
Zebrafish are an excellent model to use for studies on the effects of CNV 
because of their well-described strain-specific CNV46, such as in the 
common laboratory strains AB and Tubingen (TU). The goal of this study 
is to test the effect of copy number on the PCB-susceptibility phenotype 
to further understand genomic drivers of this trait.  
Herein we used CRISPR-Cas9 to target two strain-specific CNV 
that associate with PCB-susceptibility in zebrafish as identified in a 
recent reQTL study149. CNV_155 and CNV_343 are duplications that 
associate with changes in expression of dync1h2 or prpf4 following 
exposure to PCB-126 (3,3',4,4',5-Pentachlorobiphenyl), respectively. 
We hypothesize that reducing copy number at these loci will ablate 
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changes in gene expression and “recover” the PCB-susceptibility 
phenotype. CNV_155 appears to drive PCB-sensitivity in the TU strain, 
which manifests as a very low tolerance to PCB (developmental toxicity 
EC50 = 9 ppb PCB-12644). Conversely, CNV_343 appears to drive PCB-
sensitivity in the AB strain, which manifests as a higher tolerance 
(developmental toxicity EC50 = 131 ppb PCB-12644). We predict that 
CRISPR-Cas9 targeting to these CNV regions will result in multiple cut 
sites (Figure 5.1), loss of the duplicated sequence, and cause a reversion 
to the mean phenotype. We expect CRISPR-mutant (crispant) TU fish to 
exhibit higher PCB resistance as identified by developmental toxicity 
EC50 values higher than controls and crispant AB fish to exhibit lower 
PCB tolerance as identified by developmental toxicity EC50 values lower 
than controls. 
 
Figure 5.1: CRIPSR-Cas9 targeted at copy number duplicated sites will 
target multiple loci and produce multiple double strand breaks. 
 
Methods 
Zebrafish Care and Husbandry 
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All procedures were approved by the Portland State University 
Institutional Animal Care and Utilization Committee in accordance with 
the Office of Laboratory Animal Welfare’s Public Health Service policy. 
The zebrafish aquatic facility at Portland State University is a 
recirculating flow-through housing system (Aquaneering). Water 
temperature is maintained at 28.5°C with average pH of 7.4, average 
conductivity of 1100 uS, and a 14:10 hour light:dark cycle. Zebrafish 
are fed flake food (Tetra) supplemented with artemia and rotifers twice 
daily. 
 
CRISPR target design and microinjection 
Embryos from three strains of zebrafish (AB, Tuebingen (TU), and 
WIK) locally maintained for four generations were pair-mated. Embryos 
were collected within 15 minutes of fertilization and 1-cell stage 
embryos were microinjected with 2 nL of ribonucleoprotein (RNP) 
complex150. RNP complex was formed by combining 1 μL [750 ng/μL] 
sgRNA (Synthego) and 1 μL [3.84 mg/mL] Cas9 (Integrated DNA 
Technologies) in 10 μL of embryo media (15 mM CaCl2·2H2O, 250 mM 
NaCl, 10 mM KCl, and 15 mM MgSO4 in ultrapure water) containing 10 
ug/mL fluorescein salt and incubating at room temperature for 10 
minutes prior to loading injection needles. sgRNA was composed of a 20 
bp guide sequence, 3 bp PAM sequence, and an 80-mer SpCas9 scaffold 
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designed by Synthego (Table 5.1). Injection needles were pulled from 
thin-wall single-barrel borosilicate glass capillaries with internal filament 
(ID=0.75 mm, OD=1mm; World Precision Instruments) using a P-80/PC 
Flaming/Brown Micropipette Puller (Sutter Instrument Co.). 
Microinjection needle pull settings were as follows: temp=743, pull=60, 
vel=70, time=200. 10 ug/mL fluorescein salt in embryo media was used 
as a sham injection control. CRISPR targets were designed using 
CHOPCHOP151,152 to fall across identified CNV regions associated with 
phenotypically variable trait response eQTLs in two strains: CNV_343 in 
the AB strain and CNV_155 in the TU strain149. Successful injection was 
defined as visible fluorescence in the animal pole of 3-4 hours post 
fertilization (hpf) embryos and embryos were held in a 28.5°C incubator 
until phenotype testing at 24 hpf. 
 
Table 5.1: CNV locations and sgRNA target sequence (GRCz10) with 
PAM region underlined. 
 











For CNV_343 editing, DNA from 10 injected and 3 uninjected AB 
embryos was extracted using a modified alkaline lysis HotSHOT method 
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optimized for zebrafish tissues153. For CNV_155 editing, DNA from 3 
injected, 1 uninjected, and 3 sham injected TU embryos was extracted 
using the same method. Primers targeting CNV within identified eQTL 
were designed with the Primer3Plus tool77 (Table 5.2) to flank the 
CRISPR site (designated as “OUT” primers) or to directly anneal to the 
CRISPR target site (designated as “ON”). DNA was assayed in triplicate 
on a 96-well plate using Brilliant III SYBR Master Mix with ROX (Agilent). 
The PCR cycling protocol included preliminary dissociation (3 minutes at 
95°C) and 40 cycles of annealing and extension (95°C for 5 seconds, 
60°C for 20 seconds), per manufacturer’s protocol. A dissociation melt 
curve was also obtained to confirm single qPCR products. Fluorescence 
was measured with a Stratagene Mx3005P (Agilent) and data were 
extracted using the Stratagene MxPro data analysis software. Ct values 
were extracted by treating replicates as individuals and using the 
adaptive baseline plus moving average algorithm enhancements. Ratios 
of Ct values for ON primers versus OUT primers (ON:OUT ratio) were 
used to assess CRISPR efficiency by comparing ON:OUT ratios for 
injected vs control fish (Equation 5.1)154. 







Table 5.2: qPCR primers for validation of CNV regions identified as eQTL 
associated with PCB-induced gene expression. 
 
Target Forward primer Reverse primer 
CNV_155 OUT AAAAAGGACTGCCGCCAC AAATGGCAACAAAACAAACAGA 
CNV_155 ON CTGTATACCATTCCCATATT AAATGGCAACAAAACAAACAGA 
CNV_343 OUT TGGTCCTCCGGAATGGTTTG TGAATCAGTGACGGTTGGGG 
CNV_343 ON GCCCATTTAGCACAGGTATT TGAATCAGTGACGGTTGGGG 
  
CRISPR-induced phenotype assessment via PCB exposure 
Exposures were performed statically in 96-well plates beginning 
at 24 hpf through 120 hpf.  Each 96-well plate contained a single strain 
of zebrafish and all exposure treatments, each well contained a single 
embryo, and plates were maintained in a 28.5°C incubator for the 
duration of the assay. Randomly assigned exposure treatments 
(n=12/treatment) included media alone, vehicle (0.3% acetone, v,v), 
or PCB-126 (3,3',4,4',5-pentachlorobiphenyl) at 1, 5, 25, 125, 625, or 
3125 ppb for 24 hours (24-48 hpf). Embryos were exposed from 24 to 
48 hpf, exposure media was replaced with clean embryo media at 48 
hpf and fifty percent media changes were performed daily thereafter. 
Larvae were observed for developmental toxicity endpoints daily on an 
inverted microscope at 40X on a Leica DM IRB inverted microscope with 
a Leica DFC 450 C digital camera until 120 hpf. Sample sizes for all 
treatment groups were n=12, with the exception of AB sham-injected 
and TU CRISPR-injected groups at n=4.  
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Observations on pericardial edema, yolksac edema, reduced (non-
visible) blood flow to the body, and death were performed at 48, 72, 96, 
and 120 hpf. Additionally, heartrate was measured at 120 hpf. Edema 
was classified as a 0, 1, 2, 3, or 4 dependent upon the degree of edema 
where 0 = no edema, 1 = yolksac or pericardial edema, 2 = the presence 
of two of yolksac or pericardial edema or reduced body blood flow, 3 = 
yolksac and pericardial edema and reduced body blood flow, 4 = death 
following any observation of edema at 48, 72, 96, and 120 hpf. 
Abnormal morphology was scored at 48, 72, 96, and 120 hpf as the 
presence of curved tail, scoliosis, short body, uneven body symmetry, 
death, or unhatched at 120 hpf. Relative EC50 values were calculated 
using a probit regression model via the AAT Bioquest EC50 calculator 
(www.aatbio.com/tools/ec50-calculator) from combined heart rate, 
abnormal morphology, and edema scores at 120 hpf. 
 
Statistical Analyses 
Statistical significance of PCB-126 dose-response was determined 
for heart rate, abnormal morphology, and edema score and compared 
across groups (uninjected, sham-injected, and CRISRP-injected) within 
AB and TU separately. Significance of heart rate dose-response was 
determined using a one-way ANOVA within the base stats package in R 
using the anova() command with type I sum of squares, followed by a 
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pairwise T-test with Benjamini-Hochberg correction for multiple 
comparisons92. Significance of abnormal morphology was determined 
using a Friedman rank sum test for nonparametric statistics on nominal 
repeated-measures ratio data155. Significance of edema score was 
determined using a one-way repeated measures ANOVA in the base 
stats package in R using the aov() command followed by a post-hoc 
Tukey test for pairwise comparisons using least-squares means in the 
lsmeans package156 in R.  
 
Results 
Injection survival rates and CRISPR efficiency 
This experiment is comprised of 2569 embryos across two strains 
and three injection treatments (Table 5.3). Overall survival of uninjected 
embryos was 87.9% in AB and 23.7% in TU, which reflects the overall 
reproductive strategies of the two strains: AB tended to have smaller 
clutch sizes with higher survival at 24 hpf while TU tended to have large 
clutch sizes with decreased survival at 24 hpf. 562 AB embryos and 253 
TU embryos were subjected to PCB-susceptibility phenotyping. The 
survival rate of injected embryos was 9.11% less in AB and 9.31% less 
in TU compared to strain-matched uninjected controls. Addition of 
CRISPR RNP to the injection mixture resulted in an additional decrease 
of survival by 42.15% in AB and 10.03% in TU. Average CRISPR 
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efficiency for CNV_343 RNP was 0.49 (max = 0.85, min = 0.06) and 
average CRISPR efficiency for CNV_155 RNP was 0.13 (max = 0.60, min 
= -0.31).  
 
Table 5.3: CRISPR injection survival rates. *Confirmed injection values 











AB naïve 2 471* 414 87.90% 
AB sham 2 66 52 78.79% 
AB CNV_343 8 262 96 36.64% 
TU  naïve 2 523* 124 23.71% 
TU sham 7 743 107 14.40% 
TU CNV_155 9 504 22 4.37% 
 
Efficacy of PCB-susceptibility phenotype modulation 
Heart rate decreased relative to naïve or vehicle-exposed embryos 
following exposure to PCB-126 at 625 and 3126 ppb in both uninjected 
and sham-injected AB embryos (BH-adjusted p-value < 0.001; Figure 
5.2A). In CRISPR-injected AB embryos, heart rate decreased following 
exposure to 125, 625, and 3125 ppb PCB-126 relative to controls (BH-
adjusted p-value < 0.025). Heart rate decreased relative to naïve or 
vehicle-exposed embryos following exposure to PCB-126 at 25, 125, 
625, and 3126 ppb in both uninjected and sham-injected TU embryos 
(BH-adjusted p-value < 0.033; Figure 5.2B). In CRISPR-injected TU 
embryos, there was no difference in heart rate at any exposure level 
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tested relative to controls (BH-adjusted p-value = 0.6). See 
Supplemental Tables 5.1 and 5.2 for all pairwise p-values for AB and TU 
heart rate, respectively. 
 
Figure 5.2: Average heart rate at 120 hpf in beats per minute (bpm). 
Error bars represent 95% confidence intervals. A) AB embryos with 
CRISPR target to CNV_343, B) TU embryos with CRISPR target to 
CNV_155. Injection is indicated by color and symbol where shades of 
green represent strain AB, shades of blue indicate strain TU, circles 
indicate uninjected embryos, triangles indicate sham-injected embryos, 
and squares indicate CRISPR-injected embryos.  
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Abnormal morphology increased relative to naïve or vehicle-
exposed embryos following exposure to PCB-126 at 3125 ppb in both 
uninjected and sham-injected AB embryos (p-value < 0.04). In the 
uninjected controls, 75% of AB embryos exposed to 3125 ppb PCB-126 
showed abnormal morphology while all other treatment groups were no 
different from the controls (Figure 5.3A). This pattern was conserved in 
sham-injected AB embryos (Figure 5.3C). In CRISPR-injected AB 
embryos, abnormal morphology increased following exposure to 25, 
125, 625, and 3125 ppb PCB-126 relative to controls (p-value = 
0.0020). CRISPR-injected embryos at 25 ppb, 125 ppb, 625 ppb, and 
3125 ppb PCB-126 all had higher percentages of abnormal morphology 
(Figure 5.3E) relative to naïve or vehicle-exposed controls indicating 
efficacy of CNV_343-targeted RNP to shift the dose-response curve of 
abnormal morphology to lower doses than controls.  
Abnormal morphology increased relative to naïve or vehicle-
exposed embryos following exposure to PCB-126 at 25, 125, 625, and 
3125 ppb in both uninjected TU embryos, but this was not deemed 
significant in a Friedman rank sum test. Abnormal morphology in 
uninjected TU was observed in 64% of 25 ppb PCB-exposed, 75% of 
125 ppb PCB-exposed, and 92% of 625 and 3125 ppb PCB-exposed 
embryos (Figure 5.3B) following the expected higher PCB-sensitivity 
phenotype as compared to AB. In sham-injected TU embryos, abnormal 
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morphology increased following exposure to 1, 25, 125, 625, and 3125 
ppb PCB-126 relative to controls (p-value = 0.0440, Figure 5.3D). In 
CRISPR-injected TU embryos only embryos exposed to 125 ppb PCB-
126 had higher abnormal morphology percentages than controls, but 
due to overall toxicity of the CNV_155 RNP (Table 5.3), 88% abnormal 
morphology in the control group (Figure 5.3F), and the fact that only 4 
exposure groups were tested (naïve, 5 ppb, 25 ppb, and 125 ppb), the 
data from CRISPR-injected TU are fairly uninformative probably because 
the CNV_155 RNP was highly detrimental to normal development 




Figure 5.3: Percent of larvae with abnormal morphology. Larvae from 
strain AB (A,C,E) and TU (B,D,F) were either uninjected (A,B), sham-
injected (C,D), or CRISPR-injected at the one-cell stage, exposed to 
PCB-126 from 24-48 hpf at 1-3125 ppb, and assessed for abnormal 
morphology at 24 hour intervals until 120 hpf. P-values for significance 
determined using the nonparametric Friedman rank sum test. Dashed 
line indicates the highest abnormal morphology percentage for controls 
in each group. 
 
Average edema score increased relative to naïve or vehicle-
exposed embryos following exposure to PCB-126 at 625 and 3125 ppb 
by 72 hpf in uninjected AB embryos (p-value < 2.2e-16) with average 
edema scores of 3.2 and 3.5 at 120 hpf, respectively (Figure 5.4A). This 
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pattern was conserved in sham-injected AB embryos (p-value < 
0.0047), with the addition of an increase in edema scores in embryos 
treated with 125 ppb PCB-126 (p-value = 3.27E-08; Figure 5.4C). In 
CRISPR-injected AB embryos, average edema score increased following 
exposure to 125, 625, and 3125 ppb PCB-126 relative to controls by 72 
hpf (p-value < 0.0025; Figure 5.4E). Overall this represents a shift to 
earlier and higher toxicity of PCB-126 in CNV_343-targeted embryos 
versus sham or uninjected controls. See Supplemental Tables 5.3-5.5 
for all pairwise p-values for AB edema scores. 
Average edema score increased relative to naïve or vehicle-
exposed embryos following exposure to PCB-126 at 25, 125, 625 and 
3125 ppb by 72 hpf in uninjected and sham-injected TU embryos (p-
value < 0.0003) with average edema scores between 3.6-3.92 in 
uninjected embryos and between 2.36-3.3 in sham-injected embryos at 
120 hpf (Figures 5.4B,D).  At 120 hpf edema scores in uninjected 
embryos were significant in the 5 ppb PCB-exposed embryos (p-value < 
3.61-06), but not in sham-injected embryos. In CRISPR-injected TU 
embryos, average edema score increased following exposure to 125 ppb 
PCB-126 relative to controls at 96 hpf (p-value < 0.03.8; Figure 5.4F), 
but due to overall toxicity of the CNV_155 RNP (Table 5.3), high levels 
of edema in the unexposed group, and the fact that only 4 exposure 
groups were tested, the data from CRISPR-injected TU are not indicative 
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of CRISPR-specific effects. See Supplemental Tables 5.6-5.8 for all 
pairwise p-values for AB edema scores. 
 
 
Figure 5.4: Average edema score from 48-120 hpf. Larvae from strain 
AB (A,C,E) and TU (B,D,F) were either uninjected (A,B), sham-injected 
(C,D), or CRISPR-injected at the one-cell stage, exposed to PCB-126 
from 24-48 hpf at 1-3125 ppb, and assessed for edema at 24 hour 
intervals until 120 hpf. P-values for significance of the interaction 
between the exposure level and day to cause changes in average edema 
score determined using repeated-measures ANOVA. Dashed line 
indicates the highest average edema score for controls in each group. 
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By combining heart rate, abnormal morphology, and edema 
scores from 120 hpf, we calculated EC50 values of 512.8 ppb PCB-126 
in uninjected AB embryos and 22.5 ppb PCB-126 in uninjected TU 
embryos (Figure 5.5). Sham injections slightly increased EC50 values in 
both strains, indicating minor toxicity of the injection procedure. CRISPR 
injections in AB targeting CNV_343 reduced the EC50 by a factor of 10 
to 67.9 ppb PCB-126 relative to sham controls while CRISPR injections 
in TU targeting CNV_155 only slightly increased EC50 to 47.0 ppb PCB-
126 (Table 5.4). 
 
 
Figure 5.5: Dose-response curves for PCB-126 exposure and calculated 
EC50 values using heart rate, abnormal morphology, and edema scores 
at 120 hpf in AB (A) and TU (B) embryos. CRISPR target in AB = 
CNV_343; CRISPR target in TU = CNV_155. 
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Table 5.4: Calculated EC50 values for PCB-126 in nM and ppb with dose-
response equation.  
 
 EC50  
(nM PCB-126) 
EC50  
(ppb PCB-126) Dose-response curve 




















































By targeting CNV_343, a region that is duplicated in the AB strain 
and associated with the PCB-susceptibility phenotype, we were 
successfully able to reduce the overall sensitivity of crispant AB 
zebrafish to PCB-126. We observed AB zebrafish to have an EC50 of 
512.8 ppb PCB-126. Sham injections increased the EC50 slightly to 627.7 
ppb PCB-126, but this may be a false increase due to small sample sizes 
in the AB sham injection groups (n=4/exposure). Injection of CNV_343 
RNP resulted in a reduction of EC50 by a factor of 10 to 67.9 ppb PCB-
126 in crispant AB zebrafish, which supports our hypothesis that 
targeting the duplicated genomic region with CRISPR-Cas9 would result 
in lower tolerance of PCB-126. We were unable to fully replicate this in 
TU zebrafish using CNV_155 as a target, most likely due to the highly 
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lethal effects of the CNV_155 RNP and an overall smaller sample size, 
but the resulting trend towards an increased EC50 is in agreement with 
our predicted results for CNV_155 crispants. Further optimization of 
sgRNA:Cas9 ratios and total RNP concentration may ameliorate this 
mortality154. 
CRISPR-Cas9 genome editing is rapidly becoming a premier tool 
in genetic manipulation. Precise targeting is more and more commonly 
used to knock down gene expression in a wide variety of model 
organisms and cell cultures. CNV have proven to be a nuisance in large 
CRISPR screens by generating false-positives due to multiple target cut 
sites157–159, but we have utilized this phenomenon to specifically target 
a single duplicated region to remove all or some of the duplicated 
sequence (Figure 5.1). Our data are not able to reveal the mechanistic 
drivers of CRISPR-Cas9 CNV targeted response, but we hypothesize that 
CRISPR-Cas9 either induced multiple indels or SNPs at CNV target sites 
or simultaneous double-strand breaks resulted in complete excision of 
larger genomic regions. Nevertheless, we were able to experimentally 
ablate the effects of a non-genic CNV and alter a phenotype. 
  
Conclusion 
To our knowledge, this is the first use of CRISPR-Cas9 technology 
to target a CNV-driven phenotype. We were able to show clear and 
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statistically significant changes in developmental toxicity following 
exposure to PCB-126 in crispant AB zebrafish, and to a lesser extent, 
changes in crispant TU zebrafish. This study serves as a proof-of-
principle that CRISPR can be successfully used to target CNV and shows 
that the PCB-susceptibility phenotype is not solely driven by 
modifications to AHR, but is also driven by non-canonical endpoints. 
Furthermore, this study highlights the importance of understanding 
variation across populations. Genetic variation in human populations 
directly affect how we model the effects and prioritize clean-up of 
environmental toxicants. By confirming the interaction of CNV on PCB-
susceptibility, we hope to continue to advance our understanding of the 
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Chapter 6 
A Summary of Findings 
 
In the first chapter I introduced the four step risk assessment 
process: hazard identification, dose-response assessment, exposure 
assessment, and risk characterization. As part of the dose-response 
assessment, regulators develop a reference dose for safe levels of 
exposure using toxicity data from existing studies and the incorporation 
of several uncertainty factors. One of the weaknesses of this approach 
is the assumptions made while incorporating uncertainty factors. This 
dissertation aims to address the human variation uncertainty factor by 
investigating the effects of genomic CNV, a vastly understudied type of 
variation, on toxicant susceptibility. By fully understanding the genomic 
drivers of toxicant susceptibility, we can better predict the impacts of 
intentional (pharmacologic) and unintentional (occupational or 
environmental) exposures and incorporate our understanding into 
clean-up and prevention for sensitive populations. 
I begin by expanding our working knowledge of CNV in zebrafish. 
Prior knowledge of CNV in zebrafish focused on intrastrain (within-
strain) variation, but did not focus on interstrain (across-strain) 
variation. Expanding our knowledge of genomic differences across 
zebrafish strains is critical for application mechanisms that drive human 
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variation. By using a reciprocal comparison study design, I assessed 
CNV across three common strains of zebrafish: AB, Tuebingen, and WIK. 
I identified 1351 CNV that cover 1.9% of the most recent genome 
assembly (GRCz11), created a publically available track in the UCSC 
Genome Browser for CNV visualization and exploration, and predicted 
the transcriptional effects of the CNV. Using an extremely conservative 
± 5 Kb window, I identified 2200 genes that are likely to be affected 
(directly via overlap, or indirectly via transcriptional regulation) by CNV, 
illustrating the large impact of CNV on transcriptional variation across 
populations. 
Knowledge of genomic variation across strains is not useful in 
isolation. To move our understanding forward, I characterized the extent 
of mRNA expression variation across the same strains that I had 
assessed for CNV. One main finding from this work was that male and 
female mRNA expression in the liver is vastly different. Moving forward, 
I recommend that all analysis using adult zebrafish be partitioned into 
male and female datasets, as the overlap of differentially expressed 
mRNA between the sexes is only 14%. I found 269 mRNA transcript in 
males and 212 mRNA transcripts in females that differed significantly 
across strains. Lipid transport was over-represented in the differentially 
expressed mRNA datasets, indicating that strains may use different 
mechanisms for transport and storage of lipids. This has important 
116 
consequences in the partitioning, sequestration, and transport of 
lipophilic compounds, including PCBs. 
To evaluate the interactions between CNV and mRNA expression, 
I assessed the eQTL of the toxicant-susceptibility phenotype that varies 
across strains. To do this I exposed adult zebrafish to micro-doses of 
PCB-126 (130 ppt = 130 ng/L = 0.4 pM) and then identified PCB-induced 
mRNA expression. Using paired CNV and mRNA expression data from 
54 individuals, I was able to identify three statistically significant eQTL. 
I then mapped exposure status (unexposed, vehicle control, or PCB-
exposed) across CNV and mRNA expression plots to identify response 
eQTL (reQTL). Using this technique I narrowed my list of QTL down to 
two strain-specific mechanisms: one involving prpf4 in the Tuebingen 
strain and the other involving dync2h1 in the AB strain. This is an 
exciting peek into CNV-based eQTL. As more and more data become 
available on CNV across species, I expect a burst of discovery around 
CNV as drivers of both simple and complex phenotypes. 
To test my identified reQTL as drivers of the toxicant-susceptibility 
phenotype, I used targeted CRISPR-Cas9 editing to modify CNV and 
then assessed developmental toxicity of PCB-126. Both reQTL identified 
CNV duplications that drove a resistant phenotype in AB and a sensitive 
phenotype in Tuebingen. By removing or reducing the CNV duplications 
with CRISPR-Cas9, I hypothesized that I would be able to reverse the 
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susceptibility phenotype. Specifically, AB crispants would be less 
resistant (more sensitive) and Tuebingen crispants would be less 
sensitive (more resistant) to PCB-126 than their non-modified brethren. 
And indeed, the developmental toxicity of PCB-126—as measured by 
levels of edema, heart rate, and abnormal morphology—was reversed 
in both strains. In AB crispants the EC50 was reduced by a factor of 10 
and in Tuebingen crispants the EC50 was increased by 33%, although 
increases in Tuebingen were less statistically significant due to high 
levels of toxicity. This experiment was a solid proof-of-principle than 
CNV are directly involved in the PCB-susceptibility phenotype and that 
the mechanistic drivers of this phenotype vary across strains. 
Overall this work aims to illuminate how genetic variation affects 
phenotype, especially in relation to toxicant susceptibility, using a model 
organism to characterize and manipulate a complex phenotype. Broadly, 
my goal is to improve the risk assessment process by refining the human 
variation uncertainty factor in hazard assessment. This is not a trivial 
task. Human variation is vast and complicated. Not only do we vary at 
millions of nucleotides, we also vary in our transcriptional response 
networks. To simplify my approach, and to be able to directly modify 
and test genotype-phenotype interactions, I used the zebrafish as a 
model system. To use this system I first needed to define the existing 
variation in CNV genotype and baseline transcription, then perturb the 
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system with PCBs and identify the transcriptional response. Once 
completing those monumental tasks, I identified genetic factors that 
drive the PCB-susceptibility phenotype, modified them using CRISPR-
Cas9 genome editing, and tested the resulting phenotype. While I have 
not yet attained my overarching goal of improving the risk assessment 
process, I have clearly shown that CNV are important drivers of the 
toxicant-susceptibility phenotype and can continue in this vein of inquiry 
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Supplemental data 1.1 (xlsx) 
Annotation of genes with statistically significant changes in gene 
expression following PCB exposure in Fundulus heteroclitus plus 
annotation of blastn homolog in Danio rerio. CNV status is indicated as 
yes/no for direct overlap or indirect association (±100 Kb) of gene. File 
size: 19.4 kB 
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Supplementary Table 2.1 (xlsx) 
qPCR and standard PCR primers, amplicon sizes, and locations. File 
size: 10.5 kB 
 
Supplementary Table 2.2 (xlsx) 
1941 CNV regions in the Zv8 genome and stepwise liftover to Zv9, 
GRCz10, and GRCz11. File size: 215.2 kB 
 
Supplementary Table 2.3 (txt) 
Tabular results of Ensembl Variant Effect Predictor of 1355 CNV 
(GRCz10) queried against the RefSeq database. File size: 1.8 MB 
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Supplementary Dataset 3.1 (xls) 
Differentially expressed mRNA transcripts between males and females 
in AB. File includes probe name, log fold change, average expression, 
p-value, Bonferroni-corrected p-value, and genomic coordinates 
(danRer7/Zv9) as reported by Agilent Feature Extract and annotation 
files. Entrez gene ID, Ensembl ID, gene symbol, and gene name were 
manually confirmed and harmonized. Gene symbols and names 
highlighted in pink are differentially expressed in females. Gene symbols 
and names highlighted in blue are differentially expressed in males. File 
size: 76.0 kB 
 
Supplementary Dataset 3.2 (xls) 
Differentially expressed mRNA transcripts between males and females 
in WIK. File includes probe name, log fold change, average expression, 
p-value, Bonferroni-corrected p-value, and genomic coordinates 
(danRer7/Zv9) as reported by Agilent Feature Extract and annotation 
files. Entrez gene ID, Ensembl ID, gene symbol, and gene name were 
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manually confirmed and harmonized. Gene symbols and names 
highlighted in pink are differentially expressed in females. Gene symbols 
and names highlighted in blue are differentially expressed in males. File 
size: 54.0 kB 
 
Supplementary Dataset 3.3 (xls) 
Differentially expressed mRNA transcripts between sexes regardless of 
strain. File includes probe name, log fold change, average expression, 
p-value, Bonferroni-corrected p-value, and genomic coordinates 
(danRer7/Zv9) as reported by Agilent Feature Extract and annotation 
files. Entrez gene ID, Ensembl ID, gene symbol, and gene name were 
manually confirmed and harmonized. Gene symbols and names 
highlighted in pink are differentially expressed in females. Gene symbols 
and names highlighted in blue are differentially expressed in males. Log 
fold change, average expression, p-values, and Bonferroni-corrected p-
values are averaged between AB and WIK differential expression 
datasets (SupplementaryDataset3.1 and SupplementaryDataset3.2). 
File size: 46.5 kB 
 
Supplementary Dataset 3.4 (xls) 
Differentially expressed mRNA transcripts between AB, TU, and WIK in 
males. File includes probe name, log fold change, average expression, 
p-value, Bonferroni-corrected p-value, and genomic coordinates 
(danRer7/Zv9) as reported by Agilent Feature Extract and annotation 
files. This file also includes calculated log fold change values for each 
strain individually by taking the average of the relative log fold change: 
(AB.TU-AB.WIK)/2 = ABcalc. Calculated strain-specific log fold change 
values were then centered on zero for each probe (ABcenter). Entrez 
gene ID, Ensembl ID, gene symbol, and gene name were manually 
confirmed and harmonized. Several probes annotate to deprecated gene 
IDs; the few that fall into this category are retained in the file, but 
identified by strike-through. File size: 184.5 kB 
 
Supplementary Dataset 3.5 (xls) 
Differentially expressed mRNA transcripts between AB, TU, and WIK in 
females. File includes probe name, log fold change, average expression, 
p-value, Bonferroni-corrected p-value, and genomic coordinates 
(danRer7/Zv9) as reported by Agilent Feature Extract and annotation 
files. This file also includes calculated log fold change values for each 
strain individually by taking the average of the relative log fold change: 
(AB.TU-AB.WIK)/2 = ABcalc. Calculated strain-specific log fold change 
values were then centered on zero for each probe (ABcenter). Entrez 
gene ID, Ensembl ID, gene symbol, and gene name were manually 
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confirmed and harmonized. Several probes annotate to deprecated gene 
IDs; the few that fall into this category are retained in the file, but 
identified by strike-through. File size: 144.0 kB 
 
Supplementary Dataset 3.6 (xls) 
Differentially expressed mRNA transcripts between strains regardless of 
sex. File includes probe name, log fold change, average expression, p-
value, Bonferroni-corrected p-value, and genomic coordinates 
(danRer7/Zv9) as reported by Agilent Feature Extract and annotation 
files. Log fold change, average expression, p-values, and Bonferroni-
corrected p-values are averaged between male and female differential 
expression datasets (SupplementaryDataset4 and AddtionalFile5).This 
file also includes calculated log fold change values for each strain 
individually by taking the average of the relative log fold change: 
(AB.TU-AB.WIK)/2 = ABcalc. Calculated strain-specific log fold change 
values were then centered on zero for each probe (ABcenter). Entrez 
gene ID, Ensembl ID, gene symbol, and gene name were manually 
confirmed and harmonized. Several probes annotate to deprecated gene 
IDs; the few that fall into this category are retained in the file, but 
identified by strike-through. File size: 63.5 kB 
 
Supplementary Dataset 3.7 (xls) 
Differentially expressed mRNA transcripts that have corresponding 
evidence of circadian regulation in 4 mouse liver microarray 
experiments from the Circadian Expression Profiles Data Base (circaDB, 
http://circadb.hogeneschlab.org/). File includes a tab for each 
supplemental dataset (sd1-6) that contains Probeset_ID, Symbol, JTKP, 
JTKQ, JTKperiod, JTKphase, and Tissue columns. Probeset ID = unique 
to each microarray expression platform. Symbol = gene symbol. JTKP 
= JTK_CYCLE p-value. JTKQ = JTK_CYCLE q-value. JTKperiod = period 
of circadian oscillation, in hours. JTKphase = phase of circadian 
oscillation, in hours. Tissue = original dataset where mogene_liver = 
Mouse 1.OST Liver (Affymetrix), liver = Mouse Liver 48 hour Hughes 
2009 (Affymetrix), panda_liver = Mouse Liver Panda 2002 (Affymetrix), 
and WT_liver = Mouse Wild Type Liver (GNF microarray). “Merge” tab 
combines all circadian-driven genes from sd1-6 tabs with duplicates 
removed. “Unique” tab lists the gene symbol for the 82 genes described 
in this dataset. File size: 97.5 kB 
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Supplemental Data 4.1 (xlsx) 
Differentially expressed mRNA transcripts between PCB-exposed and 
control fish. File includes probe name, log fold change, average 
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expression, p-value, Bonferroni-corrected p-value, and genomic 
coordinates (danRer7/Zv9) as reported by Agilent Feature Extract and 
annotation files. File size: 51.4 kB 
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Supplemental Table 5.1 (xlsx) 
Heart rate in AB zebrafish. Pairwise t-test p-values with Benjamini-
Hochberg correction for multiple comparisons. File size: 13.6 kB 
 
Supplemental Table 5.2 (xlsx) 
Heart rate in TU zebrafish. Pairwise t-test p-values with Benjamini-
Hochberg correction for multiple comparisons. File size: 12.4 kB 
 
Supplemental Table 5.3 (xlsx) 
Edema score in uninjected AB zebrafish. Pairwise t-test p-values from 
Tukey honest significant difference test. File size: 16.0 kB 
 
Supplemental Table 5.4 (xlsx) 
Edema score in sham-injected AB zebrafish. Pairwise t-test p-values 
from Tukey honest significant difference test. File size: 15.7 kB 
 
Supplemental Table 5.5 (xlsx) 
Edema score in CRISPR-injected AB zebrafish. Pairwise t-test p-values 
from Tukey honest significant difference test. File size: 17.0 kB 
 
Supplemental Table 5.6 (xlsx) 
Edema score in uninjected Tuebingen zebrafish. Pairwise t-test p-values 
from Tukey honest significant difference test. File size: 16.4 kB 
 
Supplemental Table 5.7 (xlsx) 
Edema score in sham-injected Tuebingen zebrafish. Pairwise t-test p-
values from Tukey honest significant difference test. File size: 16.9 kB 
 
Supplemental Table 5.8 (xlsx) 
Edema score in CRISPR-injected Tuebingen zebrafish. Pairwise t-test p-
values from Tukey honest significant difference test. File size: 11.0 kB 
 
